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INTRODUCTION 
1. I General Introduction 
Approximately 3% of human neonates are born with one or multiple congenital 
malformations (Nadler 1986). The birth of a child with a physical or mental handicap 
presents considerable problems with which both parents and the child must cope and raises 
questions about the cause. Despite our increasing knowledge of genetics and embryology, 
many times the answers cannot be given; the etiology of the majority of malformations is 
still a maze of unknowns (table; McKusick 1992; Wilson 1977). 
Causes of malformations in man 
Known genetic transmission 
Chromosomal aberration 
Environmental causes: 
- radiation 
- infections 
- maternal metabolic imbalance 
- drugs and environmental chemicals 
Unknown 
20 % 
3-5 % 
<I % 
2-3 % 
1-2 % 
4-6 % 
65-70 % 
Fortunately, the mortality rate of many congenital malformations has dropped 
continuously over the last years thanks to the development of antenatal diagnostic 
procedures, advanced surgical techniques, and perioperative intensive care. 
In contrast however, the mortality rate of congenital diaphragmatic hernia (CDH) has not 
improved or changed in the last 30 years, despite antenatal diagnosis and tremendous 
efforts by pediatric surgeons and pediatric intensivists. CDH is a birth defect in which the 
organs of the abdominal cavity herniate into the chest cavity through an incompletely 
closed diaphragm, accompanied by unilateral or bilateral pulmonary hypoplasia with 
resultant respiratory failure after birth in the majority of the cases. The incidence of CDR 
is 1:3000 liveborns and the etiology is unknown. In 50% of the cases CDH is associated 
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with a variety of chromosomal, genetic, and nongenetic defects, but the cause of the 
absent closure of the diaphragm is still categorized as unknown (Smith 1984). 
CDR is a major problem in pediatric surgery due to the severe respiratory insufficiency 
that may occur immediately after birth, resulting in a mortality rate of 30-50% (Molenaar 
et a!. 1991). The outcome depends mainly on the gravity of pulmonary hypoplasia or on 
the combination of pulmonary hypoplasia with persistent pulmonary hypertension (Tibboe1 
et a!. 1993). The diaphragmatic defect itself is hardly a problem any more; it can be 
closed surgically. The abnormal development of the lungs is the cause of the high 
morbidity and mortality rates. 
Therefore, we were interested in the pathogenetic aspects of pulmonary hypoplasia, and 
the following specific questions were formulated and studied in a rat model of CDH and 
pulmonary hypoplasia induced by 2,4-dich10rophenyl-p-nitropheny1 (Nitrofen): 
* Is the development of the lung parenchyma different from normal? If so, in what 
respect: 
Is the architecture of the air spaces abnormal? 
Is the differentiation of the epithelia11ining of the air spaces affected? 
Is the growth pattern of the lung primordium changed? 
Is the extracellular matrix around the developing lung primordium different in 
composition? 
• Is the closing process of the diaphragm different in case of CDH? If so, in what way? 
In addition we asked the question: 
* How does Nitrofen, the compound we use to induce CDH in the rat, exert its 
teratogenic effects? 
Before these questions were addressed, a study of the literature was undertaken to assess 
what is known about normal and abnormal development of the lung. 
1.2 Nonnal development of the lung 
The onset of pulmonary development takes place in humans at 3-4 weeks, and in the 
rat on day II (Ten Have-Opbroek 1981; Ten Have-Opbroek and Plopper 1992). At that 
time the pulmonary primordium (Fig. 1) appears as a protrusion of the foregut and 
proliferates into two lung buds. Each of these lung buds gives rise to a branching tubular 
system, i.e., the primordial system of the prospective right or left lung (onset of the 
pseudoglandular phase; Ten Have-Opbroek 1981). These primordial tubules are lined by 
undifferentiated columnar epithelium. Differentiation of the primordial system into the 
prospective bronchial system and the prospective respiratory system (unit: pulmonary 
acinus) starts at 10-12 weeks in humans (Otto-Verberne et a!. 1988), and around day 16 
in the rat (Otto-Verberne and Ten Have-Opbroek 1987). The epithelium of the 
prospective bronchial system is columnar, whereas that of the pulmonary acinus is 
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Figure I Diagrams oj mammalian lung development (Ten Have-Opbroek, 1981) (A) The two lung 
buds arising from the primitive foregut (in the fat by day 11) develop into the primordial systems 
of the right and left lungs. The undifferentiated epithelium lining the primordial tubules is 
pseudostratijied columnar. (B) The prospective bronchial system and the prospective respiratory 
system (unit: pulmonary acinus) differentiate from the primordial system, in the rat by day 16. The 
basic structure in pulmonary acinus formation is the acinar tubule or sprout (lining: type 1l cells). 
Transformation of acinar tubules results in derivative structures (dilated tubules, saccules, alveoli), 
which contain not only cuboid type 1l cells in their lining, but also thinner (developing) type 1 cells 
(in the rat as oj day 20). 
initially approximately cuboid (Ten Have-Opbroek 1981). By terminal and lateral budding 
there is an increase in the number of generations of bronchial and acinar tubules. During 
further development the pulmonary acinus shows dramatic changes: the acinar tubules 
transform into derivative structures with a duct-, sac-, or pouch-like shape. These 
derivative structures are lined by cuboid alveolar type II cells and (from type II cells 
deriving) thin alveolar type I cells (Ten Have-Opbroek 1981). Light microscopical 
investigation during pulmonary development reveals the so-called pseudoglandular phase 
(humans: weeks 3-16; rats: days 11-19), followed by the canalicular phase (humans: 
weeks 13-25; rats: day 20), the saccular phase (humans: weeks 24-40; rats: days 21-22) 
and the alveolar phase (postnatally in both humans and rats; Ten Have-Opbroek 1981). 
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1.3 Abnormal lung development 
Abnormal development of human lungs occurs isolated or in association with other 
anomalies, such as hydrops fetalis, renal anomalies, hernia (including congenital 
diaphragmatic hernia and omphalocele), skeletal anomalies, and abnormalities of amniotic 
fluid, e.g. oligohydramnios and polyhydramnios (Nakamura et al. 1992). 
In all cases, lung/body weight ratios are significantly lower than in normal individuals. In 
most cases, including those with diaphragmatic hernia, the number of bronchial branches, 
radial alveolar counts, and the content of disaturated phosphatidylcholine (one of the 
components of surfactant, the substance that reduces the surface tension in the air spaces) 
are decreased, while the air-blood barrier is thicker compared to that in control lungs 
(Nakamura et al. 1992). 
Several animal models have been developed to enable studies of pulmonary hypoplasia. In 
these models pulmonary hypoplasia was induced using amniotic fluid drainage from fetal 
guinea pigs (Collins et al. 1986; Moessinger et al. 1986) or rats (Blachford and Thurlbeck 
1987), tracheal ligation in fetal rabbits (Carmel et al. 1965) or lambs (Fisk et al. 1991), 
phrenic nerve section in fetal lambs (Nagai et al. 1988), and operative creation of CDH in 
rabbits (Ohi et al. 1976) or lambs (Adzick et al. 1985; Glick et al. 1992; Pringle et al. 
1984). A disadvantage of most of these models is that a surgical procedure is required, 
and that such a procedure is not possible before the onset of organogenesis of the lung. In 
addition, fetal surgery is accompanied by high mortality rates; especially in larger 
experimental animals this may lead to high costs and ethical problems. 
Therefore, our group has used the knowledge of several researchers on the teratogenic 
effects of the herbicide 2,4-dichlorophenyl-p-nitrophenyl (Nitrofen; Ambrose et al 1971; 
Iritani 1984; Nakao and Ueki 1987) to develop a rat model for CDH and pulmonary 
hypoplasia (Kluth et al. 1990; Tenbrinck et al. 1990). When administered to the mother 
on day 10 or 12 of pregnancy Nitrofen interferes with the closing mechanism of the 
diaphragm and development of the lungs during organogenesis in the offspring. This 
model offers several advantages above the before-mentioned models: it is inexpensive, 
and easily reproducible, with shorter duration of pregnancies, multiparity, and last but not 
least, the possibility to interfere before the onset of development of the lung primordium 
and closure of the diaphragm. The mechanism of teratogenesis by Nitrofen is largely 
unknown, but evidence is accumulating that the effects are mediated via alterations in 
thyroid hormone status (Gray and Kavlock 1983; Manson 1986; Manson et al. 1984). 
1.4 Aim and approach of the present study 
Aim of the present study was to investigate 
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(I) whether there are differences in the development of the lung parenchyma between 
hypoplastic lungs and normal lungs with respect to architecture, proliferation and 
differentiation of alveolar epithelial cells, and interaction between epithelium and 
mesenchyme, 
(2) whether the closing process of the diaphragm differs in case of CDH, and 
(3) how Nitrofen exerts its teratogenic effects. 
For this purpose, the Nitrofen rat model was used. Fetuses of different gestational ages 
were collected, their lungs were dissected out and studied. Nitrofen-exposed lungs, which 
are hypoplastic, were compared to normal control lungs. 
The first part of this thesis describes the morphological characteristics of normal and 
Nitrofen-exposed late fetal rat lungs. The alveolar epithelial composition and architecture 
of the pulmonary acinus were studied by light microscopy, using histology, 
immunohistochemistry and morphometry (chapter 2). The ultrastructural features of the 
alveolar epithelial cells were studied by transmission electron microscopy (chapter 3). 
Subsequently, the development of the diaphragmatic defect and the hypoplastic lungs in 
the early embryonic and fetal period is described. The observations were made by 
scanning electron microscopy (chapter 4) and light microscopy, using histology and 
immunohistochemistry with antibodies against various differentiation and proliferation 
antigens (chapter 5). 
Evidence is accumulating that the effects of Nitrofen teratogenesis are mediated via 
alterations in thyroid hormone status. Chapter 6 describes in vitro experiments performed 
to test the effect of Nitrofen on the T3-receptor binding. 
The most important research results so far obtained in our Nitrofen rat model are 
reviewed and discussed in chapter 7. 
Finally, the last chapter of this thesis focusses on the comparability of our rat model for 
CDH and pulmonary hypoplasia and the human situation (chapter 8). 
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ALVEOLAR EPITHELIAL COMPOSITION AND 
ARCIDTECTURE OF THE LATE FETAL PULMONARY ACINUS 
An immunocytochemical and morphometric study in a rat model of 
pulmonary hypoplasia and congenital diaphragmatic hernia 
2.1 Summary 
Aim of the present study was to compare the architecture and alveolar epithelial cell 
composition of the pulmonary acinus in hypoplastic and normal fetal rat lungs. For this 
purpose, we used a rat model of pulmonary hypoplasia in association with congenital 
diaphragmatic hernia (CDR) induced by Nitrofen (100 mg on day 10 of pregnancy). 
Sections (5 I'm) from lungs of control and Nitrofen-exposed fetal Sprague Dawley rats 
with or without CDR aged 18-22 days (vaginal plug on day I, birth on day 23) were 
stained with hematoxylin and eosin. To identify developing alveolar epithelial cells, 
sections were incubated with anti-Surfactant Protein A (SP-A; rabbit anti-mouse) or 
preimmunization serum (indirect immunofluorescence). On days 18 and 19, control lungs 
and exposed lungs from fetuses with and without CDR looked similar (pseudoglandular 
stage of lung development). The prospective pulmonary acinus consisted of acinar tubules 
with small round lumens, lined by cuboid, fluorescent type II cells. Morphometric 
analysis on day 19 showed significantly smaller lung volumes and lung tissue volumes 
after Nitrofen-exposure. On day 20 (canalicular stage), some tubules were slightly dilated 
and lined by cuboid and thinner fluorescent cells; these dilated tubules were less numerous 
in lungs from exposed fetuses with CDR. On days 21 and 22 (saccular stage), the saccular 
lining consisted of cuboid to thin fluorescent cells in exposed lungs from fetuses with and 
without CDR, and fluorescent (low) cuboid cells interspersed with dark zones (type I cell 
areas) in control lungs. In the exposed lungs from fetuses with CDR, the lumens of all air 
spaces were frequently slit-like, and the septa were thicker. These phenomena gave the 
lungs a primitive, compact aspect. Morphometric analysis on day 22 showed smaller lung 
volumes and lung tissue volumes, smaller air space/tissue ratios, smaller epithelial surface 
areas, and more type II cells per surface area in Nitrofen exposed lungs than in normal 
control lungs. We conclude that Nitrofen-exposed, and thus hypoplastic, fetal rat lungs are 
retarded with respect to the differentiation of cuboid type II cells into squamous type I 
cells whether or not CDR is present and the development of the future air spaces between 
days 20 and 22 if CDR is present. 
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2.2 Introduction 
Abnormal development of the lungs occurs isolated Of in association with other 
anomalies. Associated anomalies are congenital diaphragmatic hernia (CDR), or 
oligohydramnios as found in agenesis or severe dysplasia of the kidneys, and premature 
rupture of the membranes. CDR is a serious anomaly in humans with unknown etiology 
and an incidence of 1 :3000 newborns. The abnormal pulmonary development leads to 
pulmonary hypoplasia, which forms one of the main causes of death in CDH. 
Posterolateral diaphragmatic hernia, known as Bochdalek hernia, accounts for 75 to 85 % 
of the cases and occurs most frequently on the left side. The defect in the diaphragm 
allows abdominal viscera (liver, bowel loops) to herniate into the thorax. The mortality 
rate is 40-60% despite progress in prenatal diagnosis and changing concepts in therapeutic 
approaches (Hazebroek et al. 1988; Wenstrom et al. 1991). The clinical picture and 
history of CDH has been described in several reviews (Cullen et al. 1985; Puri and 
Dewan 1989; Molenaar et al. 1991). Histologic studies describing the different stages 
during abnormal lung development and the resulting morphology in patients with CDH are 
limited and the results are divergent (Areechon and Reid 1963; Boyden 1972; Geggel et 
al. 1985; George et al. 1987; Kitagawa et al. 1971; Nakamura et al. 1991; Reale and 
Esterly 1973). These reports mention a lower number of bronchial branches and alveoli, 
and increased muscularity of the pulmonary vascular bed. 
Several studies on the pathogenesis of pulmonary hypoplasia have been performed in 
animal models. In general, an important advantage of these animal models is that they 
allow to study abnormal lung development at a number of prenatal time-points, without 
any additional damage by mechanical ventilation or medication; a problem frequently 
encountered in studies with human lung tissue. In almost all experimental studies CDH 
was created surgically in fetal sheep or rabbits. With the exception of one study (Adzick 
et al. 1985), surgical intervention was done relatively late in gestation, after closure of the 
pleuroperitonea! canals and affected late prenatal lung development (Harrison et al. 1985; 
Ohi et al. 1976; Pringle et a!. 1984). For the present study we used a rat model available 
in our department, in which pulmonary hypoplasia and CDH are induced by the herbicide 
2,4-dichlorophenyl-p-nitrophenylether (Nitrofen) administered to the mother on day 10 of 
pregnancy (Kluth et al. 1990; Tenbrinck et al. 1990; Tibboel et al. 1993). This early 
administration, 6 days before normal closure of the pleuroperitonea! canals, coincides with 
the anlage of the lung primordium. Using this model our group and other authors have 
found smaller lung volumes, lung weights, and lung weight/body weight ratios as well as 
decreased radial saccular counts (Lau et al. 1988; Stone and Manson 1981; Tenbrinck et 
al. 1990). These findings meet the criteria of Askenazi and Perlman (1979) for pulmonary 
hypoplasia in humans, and indicate that the Nitrofen-exposed rat lungs are hypoplastic 
indeed (Tenbrinck et al. 1990). The classical view is that hypoplastic lungs in CDH result 
from compression by bowel loops protruding through the diaphragmatic defect. Studies in 
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the Nitrofen model do not support this view. They have indicated that growth impairment 
is the result of a competition for space in the embryonic thoracic cavity (Kluth et al. 1993) 
rather than the result of compression, and that the lung may even be primarily hypoplastic 
(Iritani 1984; Nakao et aJ. 1990; Veki et aJ. 1990). Human case reports also suggest that 
hypoplastic lungs are not only smaller, but also immature as reflected by amniotic fluid 
lecithin/sphingomyelin ratios (Berk and Grundy 1982; Hisanaga et al. 1984). Only one 
study in the rat model gives some details concerning the alveolar epithelial lining (see 
discussion; Kimbrough et aJ. 1974). 
Aim of our study was to obtain more information about the developmental process of 
pulmonary hypoplasia in CDH by studying the architecture and alveolar epithelial 
composition of the pulmonary acinus in the hypoplastic fetal rat lung at several prenatal 
time-points (days 18-22) in the presence and absence of CDH. For general orientation, 
and for morphometry, hematoxylin and eosin-stained paraffin sections were examined by 
light microscopy. To identify developing type II and type I cells, fresh-frozen and paraffin 
sections were incubated with anti-Surfactant Protein A antiserum and, after 
immunofluorescent or enzyme staining, studied with immunofluorescence or conventional 
light microscopy. The results were compared with our findings in normal fetal rat lungs. 
For interpretation of the pictures we used well-defined criteria for recognition of fetal type 
II cells and prospective respiratory structures (Ten Have-Opbroek 1981; 1991). 
2.3 Methods 
Tissues 
Pulmonary hypoplasia in association with CDH was induced as described before (Kluth et 
al. 1990; Tenbrinck et aJ. 1990): Adult Sprague Dawley rats were mated overnight. The 
next day, if a vaginal plug was present, was considered to be day 1 of pregnancy. After a 
short anaesthesia with ether, a single dose of 100 mg Nitrofen dissolved in olive-oil was 
administered to the mothers through an intragastric tube on day 10 of pregnancy. Pregnant 
control animals received the same dose of olive-oil without Nitrofen. Fetuses were 
collected by Caesarean section from day 18 through day 22 (birth on day 23). They were 
weighed and killed after cervical intersection with a needle or intraperitoneal injection of 
Nembutal (750 Jig), depending on fetal age. Presence, position and size of a 
diaphragmatic defect were evaluated, and the lungs were dissected out. Each litter was 
randomly subdivided into four groups. Two of those groups (100 fetuses in total; 43 
Nitrofen-exposed, 57 control) were used in this study. The lungs from one group (45% 
Nitrofen-exposed, 55% control) were fixed by immersion in 3.6% buffered formalin (PH 
7.0) at 4°C; those from the other group (42% Nitrofen-exposed, 58% control) were 
immediately frozen in tissue-tek embedding medium (O.C.T. Compound, Bayer, 
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Mijdrecht, The Netherlands) as described before (Otto-Verberne and Ten Have-Opbroek 
1987) and stored at -20 0 C. 
Antisera 
Besides morphologic criteria, anti-Surfactant Protein A (SP-A) antisera were used to 
recognize both mature and immature type II alveolar epithelial cells (Le. cells containing 
multilamellai' bodies and their precursory stages vs. precursory stages only) in fetal lungs 
on the basis of a cytoplasmic staining (see Results). The antisera, previously made by Dr. 
Ten Have-Opbroek, were available in the laboratory (Oomen et al. 1990; Van Hemert et 
al. 1986). They had been prepared by injecting a rabbit with bronchoalveolar lavage fluid 
(30,000 g pellet) or lung homogenate from adult mice. The rabbit sera were absorbed with 
cross-reacting organs to obtain a lung-specific reaction. The resulting immune sera were 
called Specific Anti-Lavage Serum (SALS) and Specific Anti-Adult mouse Lung Serum 
(SAALS). They recognize the 32-35 kD proteins of SP-A when applied to blots of mouse 
lung lavage proteins (Oomen et al. 1990; Ten Have-Opbroek 1991; Van Hemert et al. 
1986), and mark type II cells strongly in several species (Oomen et al. 1990; Otto-
Verberne and Ten Have-Opbroek 1987; Otto-Verberne et al. 1988; 1990; Ten Have-
Opbroek 1975; 1979; 1981; 1991; Ten Have-Opbroek and Plopper 1992; Van Hemert et 
al. 1986). To eliminate background fluorescence at early fetal stages (Ten Have-Opbroek 
1979), SALS was additionally absorbed with homogenate made from 14 day-old-rat 
fetuses (SALS-E). This absorption does not affect the type II cell reactivity of the 
antiserum SALS (Oomen et al. 1990), because rat lungs at the age of 14 days contain only 
primordial epithelium (Otto-Verberne and Ten Have-Opbroek 1987). Preimmunization 
serum (PS) was used as control. 
Staining procedures 
The formalin-fixed tissue was dehydrated in a graded alcohol series, embedded in 
paraffin, and cut (5 I'm sections). Some of these sections were stained with hematoxylin 
and eosin (H&E); these were used for morphometry and for light microscopical 
investigation of cytology and architecture of the pulmonary acinus. Other sections were 
incubated with SAALS and used for type II cell counting. Prior to incubation the sections 
were deparaffinated in a graded alcohol series. Endogenous peroxidase activity was 
blocked with 0.3% H,O, in phosphate buffered saline (PBS, pH 7.3); to reduce 
background staining the antibodies were diluted in PBS containing 1 % ovalbumine and the 
sections were incubated with normal goat serum (1:20) for 2h. Then the primary antibody 
(SAALS 1:50; rabbit anti-mouse) was applied to the sections for overnight incubation, 
followed by incubation with goat anti-rabbit IgG (1:50; Dakopatts, Denmark) for 1 'hh, 
and with rabbit peroxidase anti-peroxidase (PAP 1:500; Nordic Immunological 
Laboratories, Tilburg, The Netherlands) also for 1 '/2h. Each incubation was followed by 
rinsing with PBS (3xlO min). Subsequently the sections were stained with 0.04% diamino 
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benzidine tetrahydrochloride (DAB) in 0.05M tris maleic acid (PH 7.6) with 0.006% H20 2 
and 0.05% NiCI2 for 10 min. The reaction was stopped with PBS and the sections were 
counterstained with methyl green. 
The fresh-frozen tissue was cut at 6 I'm, prefixed by dipping in analytic grade acetone at -
20°C (Merck, Darmstadt, FRG) and stored at -20°C. Prior to incubation with antiserum, 
the sections were further fixed in acetone at -20°C for 10 min and rinsed in PBS. They 
were incubated with SALS, SALS-E or PS in serial dilutions with PBS (1: 10-1:300) for 2 
h. After rinsing in PBS they were incubated with fluorescein isothiocyanate (FITC)-
conjugated swine anti-rabbit IgG (Dakopatts, Glostrup, Denmark) for 45 min (indirect 
immunofluorescence technique). After rinsing in PBS, the sections were mounted under a 
coverslip in a mixture of 80% glycerol and 20% PBS (pH 8.0) containing p-phenylene 
diamine (I mg/ml, which protects slides from fading) and examined with a Leitz Dialux 
20 EB immunofluorescence microscope. 
Morphometry 
Morphometric techniques were used to quantitate morphological differences between 
control and Nitrofen-exposed lungs on days 19 and 22. For this purpose three rats were 
selected at random from each experimental group (control group, Nitrofen-exposed group 
with CDH, and Nitrofen-exposed group without CDH); formalin-fixed, paraffin-embedded 
lungs were used. Lung volumes were calculated after point counting in 10 to 20 H&E-
stained sections, which were chosen at regular intervals through the whole lung, according 
to Cavalieri's principle (Michel and Cruz-Orive 1988). The same grid was used to 
determine the volume fractions of future air spaces, lung tissue, and type II cells. Type II 
cells could be recognized based on immunostaining with SAALS. The data obtained were 
used to calculate the total volume of lung tissue and the total volume of type II cells. For 
determination of the surface area of future air spaces a line grid was used (Michel and 
Cruz-Orive 1988); intercepts of the grid lines with epithelial cells were counted. 
Statistics 
All statistical comparisons between the three groups were made using a one-way analysis 
of variance (ANOY A). For the multiple comparison analysis Fisher's LSD method was 
used. A p value less than or equal to 0.05 was considered indicative of statistical 
significance. The statistical calculations were done with the statistical package SPSS/PC +. 
2.4 Results 
Macroscopy 
Exposure of Sprague Dawley rats to 100 mg Nitrofen on day 10 of pregnancy resulted in 
about 75% of the offspring in dorsal diaphragmatic hernias, which were large and left-
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sided. In addition, but only in a minority of the cases (23%), a small right-sided dorsal 
defect was present as well. In the remaining 25 % of the offspring Nitrofen-exposure had 
not resulted in diaphragmatic hernias. In the control group we did not observe any 
diaphragmatic defects at all. Macroscopically the lung on the side of the (largest) defect 
was clearly hypoplastic. In younger fetuses and in cases with a small diaphragmatic defect 
only a small part of the liver was herniated into the thorax. In older fetuses and in cases 
with larger defects (Fig. I) a substantial part of the liver, stomach and sometimes bowel 
loops were present in the thoracic cavity. 
Light microscopy 
Figure 1 Frontal section through the dorsal 
part af the thorax of a 20 day-ald-fetal rat, 
exposed to Nitro/en,' formalin-fixatioll, hema-
toxylin and eosin (H&E)-staining. This Jetus 
has a large l~ft-sided alld a small right-sided 
diaphragmatic hernia. In this section the left 
part of the diaphragm is not present at all,' 
liver and stomach are found in the thoracic 
cavity. The right part af the diaphragm is 
visible and shows a dorsomedial defect; only a 
small part of the liver protrudes. (Lu, lung; 
D, diaphragm; Lt, liver; E, esophagus; Sf, 
stomach; P, pancreas,' R, ribs). 25x. 
The architecture of the developing lung could be well studied using H&E-stained paraffin 
sections. These sections showed no difference between control and Nitrofen-exposed lungs 
on days 18 and 19, irrespective of the presence of a defect in the diaphragm. On these 
days (Fig. 2) the lungs of all three groups had a pseudoglandular appearance with a 
respiratory system consisting of tubules lined by approximately cuboid epithelium with 
large and roundish nuclei, termed acinar tubules (Ten Have-Opbroek 1979; 1991). Acinar 
tubules are the basic structures for all components of the future pulmonary acinus; they 
have a round lumen and their lining consists of (immature) type II cells (Ten Have-
Opbroek 1981). However, morphometric analysis of the lungs on day 19 showed 
significantly smaller lung volumes and significantly smaller lung tissue volumes after 
Nitrofen-exposure, whether or not CDH was present (Table I). On this day, no other 
significant differences were found between the control group and the Nitrofen-exposed 
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Figure 2 Fetal rat lungs (day 18) from control and Nttroien-exposed animals,' fonnalin fixation, 
H&E staining. (8, bronchiolus; A, pulmonary artery bronch; P, pleura). (A) Control group, 
pseudoglandular period of lung development. The respiratory system consists of acinar tubules 
only. Acinar tubules (thin arrows), which are the basic components oj the future pulmonary acinus, 
have a small lumen and a lining of cuboid type II cells (see Fig. 7C). 60x. (8) Nitrofen-exposed 
group with CDR, pseudoglandular period. A similar picture as seen in the control group (see A), 
6Ox. 
groups (Table I). On day 20 (Figs. 3A,B) all lungs were at the canalicular stage of lung 
development; the pulmonary acinus now consisted of undilated and more or less dilated 
acinar tubules. The dilated acinar tubules seemed less numerous in lungs from exposed 
fetuses with CDH (Fig. 3B) than in those from control fetuses (Fig. 3A) and exposed 
fetuses without CDH (not shown). The lining of the dilated acinar tubules consisted of 
cuboid, low cuboid, and thinner cells with an extended basis in both exposed and control 
lungs. On day 21 (not shown) control lungs and lungs from Nitrofen-exposed fetuses 
without CDH showed saccular dilations, which means that they had reached the terminal-
sac stage of lung development. The saccules were lined by a light microscopically 
indistinguishable epithelium (composition: cuboid type II cells and more or less thin 
developing type I cells). Although we also found saccules in lungs from Nitrofen-exposed 
fetuses with CDH at this age, their incidence seemed lower and their lumens (and those of 
the dilated acinar tubules) were often slit-like. In addition, septa were thicker and acinar 
tubules were still numerous. By this, the lungs appeared more compact in Nitrofen-
exposed animals with CDH than in those without CDH and in controls. The same picture, 
but even more pronounced, was found on day 22 (Figs. 4A,B,C). Morphometric analysis 
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Table 1 Morphometric alld statistical analysis of the architecture oj fetal rat lungs from the control 
group, and the Nitro.t(~n-e).posed groups (N) with or without congenital diaphragmatic hernia 
(CDH) all day 19 of gestation (11=3 rats/group). 
Control N without CDH N with CDH Statistical 
(1) (2) (3) analysis· 
Total lung volume IS.2 14.9 14.S 
(mm') 16.6 IO.S 12.4 
15.2 13.1 12.S p=0.06 
mean: 16.2 12.9 13.3 1 vs 2,3 
% Fu ture air spaces 5.2 4.7 6.1 
4.7 3.7 6.6 
U 2.0 U p=0.04 
mean: 5.0 3.5 5.9 2 vs 3 
% Lung tissue 94.S 95.3 93.9 
95.3 96.3 93.4 
95.0 9S.0 94.9 p=0.04 
mean: 95.0 96.5 94.1 2 vs 3 
Volume of lung tissue 17.3 14.2 13.9 
(mm') 15.S 10.4 11.6 
14.4 12.S 12.2 p=0.06 
mean: 15.S 12.5 12.6 1 vs 2,3 
Epithelial surface area 133.7 143.4 169.4 
(mm') 167.7 97.9 16S.2 
153.3 
.illJ. 140.5 p=O.OS 
mean: 151.6 l1S.1 159.4 2 vs 3 
* One-way analysis of variance (ANOVA) was used to compare the three groups and determine 
the p-value. Fisher's LSD method was used to determine which groups were significantly 
different from each other. 
of the lungs on day 22 showed significant differences between the control group and the 
Nitrofen-exposed group with CDH and also between the Nitrofen-exposed group without 
CDH and that with CDH; there were no significant differences between the control group 
and the Nitrofen-exposed group without CDH. The differences found were smaller lung 
volumes, smaller epithelial surface areas, smaller volume fractions of future air spaces, 
and thus larger volume fractions of lung tissue in the Nitrofen-exposed group with CDH. 
Lung tissue volumes were only significantly smaller in the Nitrofen-exposed group with 
CDH compared to those in the control group and not compared to those in the Nitrofen-
exposed group without CDH (Table 2). 
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Figure 3 Fetal rat lungs (day 20) from control and Nitrofen-exposed animals; formalin fixation, 
H&E staining. (E, bronchiolus; A, pulmonary artery branch; P, pleura). (AJ Control group, late 
canalicular period. There are many dilated acinar tubules (asterisks), 6Ox. (B) Nitro/en-exposed 
group with CDR, late canalicular period. The dilated acinar tubules (asterisks) seem fewer in 
number than in control lungs (q. A). 6Ox. 
All differences between control lungs, and Nitrofen-exposed lungs with and without CDH 
described above were found in both right and left lungs (Table 2). 
Immunohistochemistry 
Fluorescence patterns oj adult and Jetal type II cells: The antiserum SALS (rabbit anti-
mouse SP-A) used in the present study in the rat yielded a staining pattern similar to that 
reported for mouse lungs (Ten Have-Opbroek 1975; 1979; 1981; 1991). In the adult (Fig. 
5A) and fetal (Figs. 6,7) rat, type II cells displayed a bright fluorescence of the entire 
cytoplasm after incubation with SALS and FITC-conjugate. The fluorescent and frequently 
thick cytoplasmic rim contrasted strongly with the rather dark, large, and roundish 
nucleus. The fluorescent staining was either diffuse or sometimes more finely or coursely 
granular. This type of fluorescence is indicated as "cytoplasmic fluorescence". As in other 
species (Otto-Verberne et al. 1988; Ten Have-Opbroek 1975; 1981; 1991; Ten Have-
Opbroek and Plopper 1992), mature type I cells were not immuno reactive. The 
prospective bronchial epithelium in fetal rat lungs did not display any specific SP-A 
reactivity; occasionally (Fig. 6A) it showed some staining along the luminal surface. Adult 
or fetal rat lungs incubated with preimmunization serum, did not display any fluorescence 
(Fig. 5B), except for an occasional staining along the luminal bronchiolar borders. 
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Figure 4 Fetal rat lungs (day 22) from control and Nitrofen-exposed animals; formalin fixation, 
H&E staining. (B, bronchiolus,' A, pulmonary artery branch; P, pleura). (A) Control group, 
terminal-sac period. 60x. (B) Nitro/en-exposed group without CDR, normal terminal-sac period 
(Cf, A), 70x, (C) Nitrofen-exposed group with CDR; the lung has a very compact aspect, which is 
caused by the presence of fewer saccules, thicker septa, and narrower width of all air-space 
lumens (Cf, A,B), 6Ox, 
Fluorescence patterns in normal and Nitrofen-exposed developing fetal rat lungs; On days 
18 and 19 (pseudoglandular stage of lung development; not shown) the acinar tubules 
present were lined by approximately cuboid epithelial cells with large and roundish nuclei 
and a bright cytoplasmic fluorescence, which was sometimes more striking near the 
lumen, This fluorescence pattern was seen in lungs from the control group, the Nitrofen-
Table 2 Morphometric and statistical analysis of the architecture of fetal rat lungs from the control group, and the Nitrofen-exposed groups (N) 15 
with or without congenital diaphragmatic hernia (CDH) on day 22 of gestation (n=3 rats/group). 
n 
Control (I) N without CDH (2) N with CDH (3) :r: 
left right total left right total left right total » 
'" "' Total lung volume (mm') 20.7 35.1 55.8 18.0 29.4 47.4 6.3 16.3 22.6 tr1 ~ 14.4 30.4 44.8 11.9 23.5 35.4 10.0 18.8 28.9 N 
21.8 38.0 59.8 16.8 35.6 52.4 9.3 22.0 31.3 
mean: 53.5 45.1 27.6 
p=O.OI* 
% Future air spaces 47.0 37.0 42.0 43.2 33.8 38.1 18.3 20.8 20.2 
35.2 37.3 36.4 36.1 35.9 36.0 12.9 15.3 14.3 
39.5 38.9 39.2 43.9 37.8 41.0 16.2 24.1 20.2 
mean: 39.2 38.4 18.2 
p=0.OO02* 
% Lung tissue 53.0 63.0 58.0 56.8 66.2 61.9 81.6 79.2 79.8 
64.8 62.7 63.6 63.9 64.1 64.0 87.1 84.7 85.7 
60.5 61.1 60.8 56.1 62.2 59.0 83.8 75.9 79.8 
mean: 60.8 61.6 81.7 
p=0.0002* 
Lung tissue volume (mm') 11.0 22.1 32.4 10.2 19.5 29.7 5.1 12.9 18.0 
9.3 19.1 28.5 7.6 15.1 22.7 8.7 15.9 24.8 
13.2 23.2 36.4 9.4 22.2 30.9 7.8 16.7 24.5 
mean: 32.4 27.8 22.4 
p=0.06* 
Epithelial surface area (mm') 902.5 1530.4 2432.9 881.5 1211.6 2119.0 226.5 632.2 858.7 
727.2 1295.0 2022.2 584.4 1057.3 1644.1 364.0 757.6 1121.3 
937.4 1653.0 2590.4 698.1 1501.8 2193.2 359.9 902.0 1261.9 
mean: 2348.5 1985.4 lQ8lDj 
E=O.003* 
* One-way analysis of variance (ANOV A) was used to compare the three groups and determine the p-value. Fisher's LSD method was used to 
determine which groups were significantly different from each other: for all parameters there are significant differences between the three 
groups; in all cases group 3 differs from groups 1 and 2, except for lung tissue volume where group 3 differs only from group 1. 
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Figure 5 Fresh-Jrozen sections of rat lung. (A) Adult rat lung incubated with SALS (1:300, rabbit 
anti-mouse SP-A, indirect immunofluorescence), Note the bright cytoplasmic staining of alveolar 
type If cells (arrows) and the absence of fluorescence where mature type I cells, which are SP-A 
negative, line the alveolar wall. 350x. (B) Fetal rat lung (day 22) incubated with pre-immunization 
serwn (1:50, indirect immunofluorescence). There is no fluorescence at all. 350x. 
exposed group with CDH, and the Nitrofen-exposed group without CDH. On day 20 
(canalicular stage, Fig. 6A,B) in all three groups dilated acinar tubules were present 
besides undilated forms; these dilated forms were lined by cuboid, low cuboid and thinner 
cells with an extended basis. These cells all exhibited a cytoplasmic fluorescence pattern, 
although the intensity of the fluorescence varied considerably. When viewed en face, these 
thinner cells may be seen as weakly fluorescent sheets dispersed between brightly 
fluorescent type II cells. On day 21 (early terminal-sac stage; not shown), the epithelial 
lining of the saccules present consisted of cuboid and thinner cells with fluorescence of the 
entire cytoplasm and thin cells in which fluorescence was restricted to the borders. In 
these thin cells, fluorescence was found mainly at the basis of the cell with the nucleus 
and remaining cytoplasm shadowily visible above it. In control lungs only a linear 
fluorescence pattern was seen along the luminal surface in some cases and occasionally 
very thin cells could be found without any fluorescence. The latter two patterns (linear 
fluorescence and occasional absence of fluorescence) were not observed in Nitrofen-
exposed lungs from fetuses with or without CDH. On day 22, in control lungs (Fig. 7A) 
the saccular lining consisted of some fluorescent cuboid cells interspersed with more or 
less dark areas, i.e., sites where more or less mature type I cells must occur (see 
Discussion); truly dark areas (representative for mature type I cells) were also present. 
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Figure 6 Fetal rat lungs (day 20) from Nitrofen-exposed and unexposed animals; Jresh-jrozen 
sections incubated with SALS 1 :200 (indirect immunofluorescence), (A) Control group; acinar 
tubules with a small lumen (asterisks) and dilated acinar tubules with approximately cuboid 
fluorescent type II cells (arrowheads), The dilated tubules also show thinner fluorescent cells with 
a frequently extended basis (arrows). Bronchial epithelial cells show some fluorescence along the 
luminal surface, probably caused by presence of surfactant (SP-A) or conjugate between ruffles or 
cilia (see Discussion). (B, bronchiolUJ). 35Ox. (B) Nitro/en-exposed group with CDR; acinar 
tubules (asterisks) with cuboid fluorescent type II cells (arrowheads) and dilated tubules with also 
thinner fluorescent cells (arrows); a similar picture as seen in the control group (C;f A). 35Ox. 
However, in both groups of Nitrofen-exposed lungs (Fig. 7B,C) the saccules resembled 
those seen on day 21. They were still lined by thinner (besides cuboid) fluorescent cells 
and very thin fl uorescent cells; few or no dark zones were present in lungs from Nitrofen-
exposed fetuses both with (Fig. 7C) and without (Fig. 7B) CDH. Many acinar tubules 
with cuboid fluorescent epithelium were seen in the lungs from Nitrofen-exposed fetuses 
Figure 7 Fetal rat lungs (day 22) jrom Nitro/en-exposed and unexposed animals; jresh-jrozen 
sections incubated with SALS (indirect immunofluorescence). (AJ Control group, SALS 1:100; 
saccules lined with some fluorescent cuboid type II cells (arrowheads) interspersed with more or 
less dark zones, indicative jar the presence oj more or less mature type I cells. Note that there 
are only a few truly dark zones (small arrowheads, Cf Fig. SA). 3S0x. (B) Nitrofen-exposed 
group without CDR, SALS 1 :200; the entire saccular lining is still brightly fluorescent (C;f A). 
It shows some fluorescent cuboid type II cells (arrowhead), fluorescent thinner cells (arrows) 
and linear staining (thin arrow},). The latter two patterns suggest retardation of type I cell 
differentiatian in the exposed lungs. 35Ox. (C) Nitrofen-exposed group with CDR, SALS 1;100; 
the entire saccular lining is still fluorescent as in lungs from Nitrojen-exposed rats without CDR 
(Cf B). In addition these lungs generally show more acinar tubules (asterisks). 3S0x. 
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Table 3 Morphometric and statistical analysis of type II cell volumes in fetal rat lungs from the 
control group, and the Nitro/en-exposed groups (N) with or without congenital diaphragmatic 
hernia (CDH) on day 19 of gestatiOn (n=3 rats/group). 
Control N without CDH N with CDH Statistical 
(I) (2) (3) analysis* 
% Type II cells in lung tissue 23.9 27.0 24.7 
24.0 41.2 24.3 
30.9 no 32.6 p=0.73 
mean: 26.3 30.4 27.2 
% Type II cells in total lung 22.5 25.7 23.0 
22.9 39.7 22.6 
29.3 2b2 31.1 p=0.68 
mean: 24.9 29.3 25.6 
Tota] volume of type II cells 4. I 3.8 3.4 
(mm') 3.8 4.3 2.8 
4.5 :LQ 4.0 p=0.33 
mean: 4.1 3.7 3.4 
* One-way anagsis of variance CANOY A) was used to compare the three groups and determine 
the p-value. isher's LSD method was used to determine which groups were significantly 
different from each other. 
with CDH. This picture differed greatly from that seen in control lungs (Fig. 7A), where 
few acinar tubules were seen and relatively many dark zones were present in the saccular 
lining. The differences between control lungs and Nitrofen-exposed lungs from fetuses 
with and without CDH described above were found in both the ipsilateral and the 
contralateral lungs. 
Volume fraction of type 11 cells in nonnal and Nitrofen-exposed fetal rat lungs: After 
incubation with SAALS and PAP, followed by staining with DAB and methyl green, type 
II cells in formalin-fixed paraffin sections displayed a similar cytoplasmic staining pattern 
as in fresh-frozen sections incubated with SALS and FITC. However, the cytoplasm was 
now visible as a black rim. Counting the volume fraction of type II cells in total lung 
tissue revealed no differences between either of the three groups on day 19 (Table 3). On 
day 22, however, the volume fraction of type II cells in lung tissue was significantly 
smaller in control lungs than in Nitrofen-exposed lungs without CDH, and also in 
Nitrofen-exposed lungs with CDH than in those without CDH (Table 4). The difference 
between control lungs and Nitrofen-exposed lungs with CDH was not significant. The 
volume fraction of type II cells in total lung was significantly smaller in control lungs than 
in Nitrofen-exposed lungs without CDH; there were no significant differences between the 
other groups (Table 4). The total volume of type II cells in the lung was significantly 
smaller in Nitrofen-exposed lungs with CDH than in control lungs and Nitrofen-exposed 
lungs without CDH (Table 4). 
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Table 4 Morphometric and statistical analysis of type II cell volumes in fetal rat lungs from the 
control group, and the Nitrojen-exposed groups (N) with or without congenital diaphragmatic 
hernia (CDH) on day 22 qf gestatIOn (n=3 rats/group). 
Control N without CDH N with CDH Statistical 
{l) (2) (3) analysis* 
% Type II cells in lung tissue 25.3 29.4 19.1 
21.2 31.6 20.5 
26.1 29.7 24.9 f=O.OI 
mean: 24.2 30.2 21.5 ,3 vs 2 
% Type II cells in total lung 14.7 18.4 15.2 
13.5 20.3 17.6 
15.9 17.5 19.5 p=0.06 
mean: 14.7 18.7 17.4 1 vs 2 
Total volume of type II cells 8.2 8.7 3.4 
(mm') 6.0 7.2 5.1 
9.5 9.2 .u ¥=0.04 
mean: 7.9 8.4 4.9 vs 1,2 
* One-way anagsis of variance (ANOVA) was used to compare the three groups and determine 
the p-value. isher's LSD method was used to determine which groups were significantly 
different from each other. 
2.5 Discussiou 
SP-A-reactivity and alveolar epithelial cell development in normal fetal lungs 
In fetal lungs, identification of specific cell types in the epithelium lining the future air 
spaces has long been a major problem, because specific cell markers were not available. 
Light- and electron microscopical studies of mammalian lungs performed in our laboratory 
have provided detailed information on type II and type I alveolar epithelial cells at early 
and later stages of prenatal and postnatal lung development (Brandsma et al. 1993; Otto-
Verberne et al. 1988; 1990; Otto-Verberne and Ten Have-Opbroek 1987; Ten Have-
Opbroek 1975; 1979; 1991; Ten Have-Opbroek and Plopper 1992) and in adult lungs (Ten 
Have-Opbroek 1986; Ten Have-Opbroek et al. 1991). These studies and other studies of 
late prenatal, postnatal and adult lungs (Adamson and Bowden 1975; Evan et al. 1975) 
have shown that type II cells are the stem cells for type I cells during pre- and postnatal 
lung development. Criteria to recognize mature and immature type II cells at the light 
microscopical level are the approximately cuboid shape, the large and roundish nucleus, 
and staining of the entire cytoplasm for the surfactant protein SP-A. In contrast, mature 
type I cells are squamous, and invisible by light microscopy, and do not show SP-A 
antigenicity (Otto-Verberne and Ten Have-Opbroek 1987; Otto-Verberne et al. 1988; Ten 
Have-Opbroek 1975; 1981; 1991; Ten Have-Opbroek and Plopper 1992). Developing type 
I cells have intermediate cell properties between type II and type I cells (low cuboid to 
squamous shape; waning cytoplasmic fluorescence) (Otto-Verberne and Ten Have-Opbroek 
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1987; Otto-Verberne et al. 1988; Ten Have-Opbroek 1975; 1981; 1991; Ten Have-
Opbroek and Plopper 1992). In the light of these data, we conclude that the thinner 
fluorescent cells and the linear fluorescence we found in the pulmonary acinus of fetal rat 
lungs on days 20-22 after incubation with SALS and FITC-conjugate represent developing 
type I cells. The fact that developing type I cells are not easily detected in adult lungs may 
be a result of lower incidence or shorter existence of these transitional forms in mature 
lungs (Ten Have-Opbroek 1991). 
In agreement with earlier findings in prenatal mouse lungs Ten Have-Opbroek 1991) the 
prospective bronchial epithelium in fetal rat lungs, which consists of columnar ciliated 
cells and morphologically immature Clara cells, does not display any SP-A reactivity. 
Occasionally, staining at the luminal surface of a bronchiolus is seen. This occasional 
fluorescence along the apical border of bronchioles prenatally can also be found in 
immunohistochemical controls. It must therefore result from retention of conjugate or 
surfactant (SP-A) between cilia or in epithelial ruffles Ten Have-Opbroek 1991). 
Cytoplasmic staining prenatally is restricted to type II cells and developing type I cells. 
Immunoelectron microscopy of prenatal mouse lungs has confirmed all these light 
microscopical conclusions (Ten Have-Opbroek 1991; Ten Have-Opbroek and de Vries 
1993). The same anti-SP-A serum was used to follow the development of the alveolar 
epithelium in Nitrofen-exposed and control fetal rat lungs. 
Effect 0/ Nitro/en-exposure on lung development 
As reported by our group (Tenbrinck et al. 1990), exposure of pregnant Sprague Dawley 
rats to Nitrofen leads to pulmonary hypoplasia in both right and left lungs whether or not 
CDH is present, shown by individual determination of left and right lung weights, body 
weight and radial saccular count (RSC). Mean body weights, lung weights, lung 
weight/body weight ratios, and RSC in the Nitrofen-exposed group with CDH were 
significantly lower than in the non-exposed control group. No correlation was found 
between the size of the defect and the ipsilateral lung weight, and, in all cases a 
significant decrease of lung weight was observed on the contralateral side as well. Right 
lung weight/left lung weight ratios in the Nitrofen-exposed group did not differ 
significantly from those in the control group. The Nitrofen-exposed group without CDH 
showed intermediate values. The results from our present study indicate that this is also 
true for lung volume and lung tissue volume. A significant decrease of these volumes is 
observed in the Nitrofen-exposed group with CDH, while right lung/left lung ratios do not 
differ significantly in either of the groups. In other words, both left and right lungs are 
affected to the same extent. The exposed group without CDH again showed intermediate 
values. As further explained below, our study also indicates that hypoplastic fetal rat lungs 
obtained after Nitrofen-exposure of pregnant Sprague Dawley rats (100 mg on day 10) 
have a different epithelial composition irrespective of the presence of CDH and a different 
architecture of the pulmonary acinus only if CDH is present. 
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Architecture of the pulmonary acinus in hypoplastic lungs 
In lungs from control fetuses and Nitrafen-exposed fetuses without CDH, increase of the 
size of future air spaces and decrease of the thickness of alveolar septa leads to a more 
open aspect of the lung on day 22 than on day 20. This picture differs greatly from that 
seen in lungs from Nitrofen-exposed fetuses with CDH: the aspect of the hypoplastic lung 
is more compact on day 22 than it is on day 20, despite the fact that saccule formation 
takes place. Larger future air spaces seem less abundant and alveolar septa thicker. This 
phenomenon becomes more pronounced with increasing gestational age, and is observed in 
both lungs. In other words, there is not a direct correlation between these changes and the 
site of the diaphragmatic hernia. Morphometric analysis confirms this morphologic 
observation: the volume fraction of lung tissue is significantly higher in the Nitrofen-
exposed group with CDH than in the other two groups. In addition, the ratio of total lung 
tissue volumes of control lungs and lungs from the Nitrofen-exposed group with CDH is 
smaller than the ratio of epithelial surface areas of these two groups. This means that in 
an equal volume of lung tissue a smaller epithelial surface area is present in the Nitrofen-
exposed group with CDH, which is in agreement with the morphologic picture of these 
lungs with less well-developed saccules and thicker septa. Studies in the fetal lamb model 
in which CDH is created surgically in the second trimester of pregnancy (Pringle et al. 
1984; Pringle 1989) also mention an immature appearance of the lung, with smaller air 
spaces and thicker septa. Ohi et al. (1976) using a similar surgical model in rabbits state 
that the lungs are not as fully matured as the lungs of normal newborn rabbits, but look 
more atelectatic than hypoplastic. In their model CDH is created in the third trimester of 
gestation. The differences between the results from the experiments of Ohi et al. (1976) 
and Pringle et al. (1984; 1989) might therefore be due to the different timing of CDH 
creation. In both experiments, however, CDH was created relatively late during gestation, 
after closure of the pleuroperitoneal canals, while in our rat model the teratologic agent is 
administered even before the appearance of the lung bud. In the rat model, we are the 
first to describe the architecture of the lung in detail. It is difficult to compare our results 
with those in other studies (Kimbrough et a1. 1974; Lau et al. 1988; Stone and Manson 
1981), because Nitrofen-exposure differs in dose and timing, with divergent results. Lau 
et al. (1988) find fewer but larger air spaces, while Kimbrough (1974) and Stone and 
Manson (1981) find atelectasis without any further obvious differences or immaturity. 
Human case studies of pulmonary hypoplasia associated with CDH (Boyden 1972; George 
et al. 1987; Nakamura et a1. 1991) do mention an immature appearance of the pulmonary 
acinus but these studies do not further specify the respiratory structures present. 
The present study in H&E-stained paraffin sections also demonstrates that in the lungs 
from Nitrofen-exposed fetuses with CDH the lumens of the air spaces are slit-like and not 
expanded like those in control lungs and lungs from fetuses without CDH. Similar pictures 
were shown before in newborn rats using about the same rat model (Kimbrough et al. 
1974; Stone and Manson 1981), in rabbit lungs (Ohi et al. 1976), and in lungs of term 
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human patients with CDH (Boyden 1972; Reale and Esterly 1973). Some studies that have 
used lungs from cases with CDH fixed under pressure after canulation of the trachea, as 
advocated by Burri et a!. (1974) for studying postnatal lungs, do not mention the compact 
picture (George et a!. 1987; Kitagawa et a!. 1971), which suggests that artificial expansion 
of the future air spaces took place. However, to the contrary, lungs from our Nitrofen-
exposed rats without CDH or from animal models for pulmonary hypoplasia not 
associated with CDH (Collins et a!. 1986; Fisk et a!. 1991; Seegmiller et a!. 1986) not 
show this atelectatic picture. 
Besides higher volume fractions of lung tissue and smaller total lung volumes, lungs from 
the Nitrofen-exposed group with CDH also have smaller total lung tissue volumes, which 
means that these lungs are not only atelectatic, but anyhow smaller. The relatively small 
epithelial surface areas show that these lungs are also immature. In summary, we find 
smaller, atelectatic, and immature lungs after Nitrafen exposure if CDR is present. Lungs 
in the Nitrofen-exposed group without CDH are smaller, but not atelectatic and not 
immature, as shown by normal volume fractions of lung tissue and relatively normal 
epithelial surface areas. From these findings, we conclude that the presence of viscera in 
the thoracic cavity protruding through a defect in the diaphragm probably causes the 
narrow width of the air spaces and thus the compact structure of the lungs. Competition 
for space in the thorax may also play a role in the abundance of acinar tubules and the 
deficiency of well developed saccules because this picture is seen in lungs from exposed 
fetuses with CDH but not in those from fetuses without CDH. Finally, decrease of fetal 
breathing movements might also contribute to the immaturity of the lungs, as shown in 
oligohydramnios, chondrodystrophia, or phrenic nerve section (Collins et al. 1986; Fisk et 
al. 1991; Nagai et a!. 1988; Seegmiller et a!. 1986). Exposed fetuses without CDH have 
no impairment of their breathing movements, nor immaturity of the architecture of the 
lung. 
Epithelial composition of the pulmonary acinus in hypoplastic lungs 
Comparison of the combined immunohistochemical and H&E-staining results in 
hypoplastic and control lungs indicates that there are no differences on day 18 and day 19. 
However, on days 20 through 22 the differences are striking. Based on 
immunofluorescence pictures, on day 22 the main differences in alveolar epithelial 
composition between the hypoplastic and control lungs are the following. First, the 
abundance of mature type I cells in hypoplastic lungs is apparently smaller, suggesting a 
retarded differentiation of type II into type I alveolar epithelial cells. Second, the 
abundance of type II cells and developing type I cells seems to be greater in hypoplastic 
lungs. Morphometric analysis of the lungs shows that volume fractions of type II cells in 
lung tissue and in total lung are significantly smaller in control lungs than in Nitrofen-
exposed lungs without CDH, but not smaller than in those with CDH, whereas the total 
volume of the type II cell population is larger in the control group than in the Nitrofen-
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exposed group with CDH. However, when the total epithelial surface area of the lungs of 
the three groups is taken into account, it turns out that an equally large surface area is 
occupied by a significantly larger volume of type II cells in the two Nitrofen-exposed 
groups compared to the control group. Therefore, we can conclude that the alveolar 
surface present is lined by relatively more type II cells and less type I cells after Nitrofen-
treatment. Protruding viscera can not be held responsible for the occurrence of these 
phenomena, because they occur also in lungs from exposed fetuses without CDH; the 
pathogenesis is therefore not clear. 
Our conclusions regarding the alveolar epithelial maturation in hypoplastic fetal rat lungs 
are in line with results of ,other investigators using a similar rat model. Kimbrough et at. 
(1974) studied the lungs by light- and electron microscopy but only on day 21; they state 
(based on morphological pictures only) that on that day most alveolar cells are cuboidal 
and resemble cells of less gestational age. Their conclusion agrees with our finding of the 
presence of relatively more type II cells around that time. Our conclusions also agree with 
those obtained in models that interfered later in gestation. In the fetal lamb model, in 
which pulmonary hypoplasia occurs after surgical creation of a diaphragmatic hernia, 
increase of the number of mature type II cells is described by several authors (Hashimoto 
et al. 1985; Pringle et al. 1984). These conclusions however are not based on 
morphometric data. In a fetal lamb model of pulmonary hypoplasia in association with 
oligohydramnion, Fisk et al. (1991) have obtained similar results. They find relatively 
more type II cells and less type I cells in term hypoplastic lungs compared to normal 
lungs, but they also find many undifferentiated alveolar epithelial cells. They do not 
describe on which criteria the recognition of these three cell types is based. We are the 
first to quantitate the differences between normal and hypoplastic lungs using well defined 
criteria for the recognition of mature and immature type II cells. 
These light microscopical and immunofluorescence studies do not allow conclusions about 
the morphological or functional maturity of the type II cells in hypoplastic lungs in 
ultrastructural and biochemical respects. Our study describing these aspects has recently 
been published (Brandsma et a1. 1993). 
In summary we conclude that Nitrofen-exposed fetal rat lungs: 1) have smaller lung 
volumes and lung tissue volumes from at least day 19 onwards; 2) are retarded with 
respect to the differentiation of cuboid type II cells into squamous type I cells; 3) have 
smaller total volumes of type II cells if CDH is present, but their alveolar surfaces are 
lined by relatively more type II cells and less type I cells whether or not CDH is present; 
4) are atelectatic, and retarded with respect to the development of the future air spaces 
between days 20 and 22 if CDH is present. 
We also conclude that transformation of cuboid fluorescent alveolar type II cells into 
squamous, not-fluorescent alveolar type I cells starts from day 20 in the fetal rat; the 
attenuating cells seem to lose their SP-A reactivity fitst apically and later also basally. 
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ULTRASTRUCTURAL FEATURES OF ALVEOLAR 
EPITHELIAL CELLS IN THE LATE FETAL PULMONARY 
ACINUS 
A comparison between normal and hypoplastic lungs, using a rat model 
of pulmonary hypoplasia and congenital diaphragmatic hernia 
3.1 Abstract 
Aim of this study was to describe and compare the ultrastructural features and 
functional maturity of alveolar epithelial cells in hypoplastic and normal fetal rat lungs. 
Pulmonary hypoplasia in association with congenital diaphragmatic hernia was induced in 
fetuses by administration of 2,4-dichlorophenyl-p-nitrophenylether (Nitrofen) to pregnant 
Sprague Dawley rats (100 mg on day 10 of gestation). Lung tissue of Nitrofen-exposed 
and control fetal rats aged 19-22 days (vaginal plug day I, birth day 23) was embedded in 
Epon. Semithin (1 I'm) toluidine blue-stained sections were examined by light microscopy; 
ultrathin sections (ca.80 nm) were studied by transmission electron microscopy. In 
bronchoalveolar lavage fluid from control and Nitrofen-exposed fetuses (day 22) 
phospholipid fractions and surfactant protein A content were measured (semi) 
quantitatively. On day 19 both control and Nitrofen-exposed lungs contained only cuboid 
alveolar epithelial cells; from day 20 there were cuboid, low cuboid and thinner epithelial 
cells. The (low) cuboid cells contained large glycogen fields, some precursory stages of 
multilamellar bodies (MLBs), and just a few mature MLBs on day 19 and 20; smaller 
glycogen fields, more precursory stages and more mature MLBs on day 21; and little or 
no glycogen but many precursory stages and mature MLBs on day 22. The thinner cells 
contained little or no glycogen and a few precursory stages of MLBs on days 20 through 
22; very thin cells on day 22 contained neither glycogen nor any precursory stages of 
MLBs. MLBs and tubular myelin were seen in the lumens of future air spaces from day 
20 onward. Nitrofen-exposed lungs differed from control lungs in that inclusion bodies 
(IBs) were less numerous in (low) cuboid alveolar cells on days 19 and 20, and more 
glycogen was seen on day 22. In addition, intra- and extracellular flMLBsu in exposed 
lungs more often had an unusual appearance, i.e. a confluent structure and higher electron 
density. However, despite morphologic differences, there was no clear difference in 
phospholipid composition and SP-A-content per mol phospholipid in bronchoalveolar 
lavage fluid. 
We concluded that morphologically hypoplastic lungs are less mature near term, without 
an apparent effect on surfactant composition. 
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3.2 Introduction 
Congenital diaphragmatic hernia (CDH) is a serious anomaly in humans. The incidence 
of CDH is I :3000 newborns, the etiology is unknown and the mortality rate is 40-60% 
(Wenstrom et al. 1991). One of the main causes of death in children with CDH is the 
associated pulmonary hypoplasia (review Molenaar et a1. 1991). Improvement of 
therapeutic possibilities for children with respiratory distress due to pulmonary hypoplasia 
requires insight in normal and abnormal pulmonary development, morphology and 
biochemistry. Studies in human cases hardly allow these kinds of investigations at specific 
prenatal time-points, or without any additional damage by mechanical ventilation 
(barotrauma, oxygen toxicity). Therefore, to obtain further information, we use a rat 
model (Kluth et al. 1990; Tenbrinck et al. 1990), in which pulmonary hypoplasia and 
CDH are induced by the herbicide 2,4-dichlorophenyl-p-nitrophenylether (Nitrofen) 
administered to the mother on day 10 of pregnancy. Administration of a single dose of 
this teratologic agent very early in gestation, i.e. 6 days before normal closure of the 
pleuroperitonea! canals and just before anlage of the lung primordium, interferes with 
diaphragmatic and pulmonary development. Nitrofen-exposed neonatal rat lungs are 
hypoplastic on both left and right side (Lau et a1. 1988; Stone and Manson 1981; 
Tenbrinck et a1. 1990) according to the criteria of Askenazi and Perlman (1979) for 
human species. Macroscopically, this exposure results in dorsal diaphragmatic hernias, 
which are large and left-sided, in about 80% of the offspring. In addition, but only in a 
minority of the cases (26%), a small right-sided dorsal defect is present as well. In 
younger fetuses and in cases with a small diaphragmatic defect only a small part of the 
liver herniates into the thorax, whereas in older fetuses and in cases with larger defects a 
substantial part of the liver, stomach, and sometimes bowel loops are present in the thorax 
as well. In Nitrofen-exposed fetuses without CDH the lungs are also hypoplastic 
(Tenbrinck et al. 1990). Nitrofen possibly inhibits early lung proliferation or 
differentiation via alterations in the thyroid hormone status of the embryo (Manson 1986) 
by a direct interaction with the nuclear thyroid hormone receptor (our own unpublished 
results). The existence of such an early effect of Nitrofen on lung development would 
explain why results from studies in which CDH is created surgically in fetal lambs, differ 
from those obtained in our study (see discussion). Light microscopically, there is a 
retarded differentiation of cuboid type II cells into squamous type I cells and a retarded 
development of the future air spaces between days 20 and 22 in lungs from Nitrofen-
exposed fetuses with CDH (Brandsma et a1. 1992a). However, the techniques used (light 
microscopy and indirect immunofluorescence) do not allow conclusions about the 
morphological or functional maturity of the alveolar epithelial cells. 
Therefore, aim of the present study was to investigate the ultrastructural morphology and 
functional maturity of type I and type II cells in the developing hypoplastic fetal rat lung. 
For general orientation semithin Epon sections were stained with toluidine blue and 
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examined by light microscopy. To study alveolar epithelial cells ultrathin Epon sections 
were examined by transmission electron microscopy (rEM). Morphological and functional 
maturity of type II cells was determined by TEM (presence of precursory forms or mature 
multilamellar bodies; Kikkawa and Spitzer 1969; Ten Have-Opbroek et al. 1988, 1990) 
and by (semi)quantitative measurement of phospholipid- and SP-A-content in 
bronchoalveolar lavage fluid on day 22. The results were compared with our findings in 
normal fetal rat lungs. 
3.3 Materials and Methods 
Animal treatment 
Pulmonary hypoplasia in association with CDH was induced as described before (Kluth et 
al. 1990; Tenbrinck et al. 1990): Adult Sprague Dawley rats were mated overnight. The 
next day, if a vaginal plug was present, was considered to be day one of pregnancy. A 
single dose of 100 mg Nitrofen dissolved in olive-oil was administered to the ether-
drowsed mothers through an intragastric tube on day 10 of pregnancy. 85 Nitrofen-
exposed fetuses and 50 control fetuses were collected by Ceasarian section from day 18 
through day 22 (birth on day 23). They were weighed and pithed. A number of control 
and Nitrofen-exposed fetuses underwent bronchoalveolar lavage. Finally, in all fetuses 
presence, position, and size of a diaphragmatic defect were evaluated. 
Microscopy 
From 19 Nitrofen-exposed fetuses with CDH and 17 age-matched control fetuses (day 18-
22) the lungs were dissected out and fixed by immersion in 2 % paraformaldehyde and 
1.25% glutaraldehyde in 0.1 M cacodylate buffer (PH 7.4) containing 0.075% CaCl, for 
24 hr at 4°C. The tissue was postfixed for 2 hr in I % osmium tetroxide in 0.1 M 
cacodylate buffer (PH 7.4) at room temperature. After dehydration via a graded alcohol 
series (70-100%, each step lasting 15 min), the tissue was transferred to a mixture of 
propylene oxide and Epon (1:1) for 45 min, stored overnight in Epon in an exsiccator 
under low vacuum for better penetration of Epon into the lung tissue, and then embedded 
in fresh Epon. 
Semithin sections (1 I'm) were cut, using a glass knife and a LKB ultramicrotome (LKB-
produkter AB, Stockholm, Sweden). The sections were stained with toluidine blue and 
used for light microscopical investigation of cytology and architecture of the pulmonary 
acinus and for selection of representative fields for electron microscopy. Ultrathin sections 
(ca. 80 nm) were cut with a LKB ultramicrotome using a diamond knife (Diatome Ltd., 
Bienne, Switzerland). The sections were mounted on copper RI00a grids (Veco, Eerbeek, 
The Netherlands), stained with uranyl acetate 7% for 45 min and lead citrate for 10 min, 
and examined with a Philips 201 electron microscope at 60 kV. 
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Bronchoalveolar lavage 
33 Control and 52 Nitrofen-exposed fetuses with CDH (day 22) underwent 
bronchoalveolar lavage. After inserting a tube into the trachea, the lungs were washed in 
situ with 0.05-0.35 ml 0.9% NaCI (37°C) depending on air space volume, 3-10 times or 
until leakage occurred. Each lavage volume was twice infused and withdrawn slowly. To 
preserve surfactant associated proteins the protease-inhibitor phenylmethylsulfonyl fluoride 
(PMSF, 0,25 mM) was added to the lavage fluid. Then the lavage fluid was centrifuged 
for 10 min at 350 g to remove cells and macrophages, saturated with nitrogen to prevent 
degradation, and stored at -20°C. If required, lavage fluid from a number of animals was 
pooled to get appropriate volumes for further processing. 
Phospholipids in bronchoalveolar lavage fluid 
Lipids were extracted from the lavage fluid with dichloromethane and methanol (2: 1 v/v). 
Total phospholipid content was determined as described before (Fiske and Subbarow 
1925). The various phospholipid classes were separated by thin-layer chromatography on 
HPTLC plates (Merck, 60F254, Germany), using chloroform / methanol / 2-propanol / 
0.25% KCl / triethylamine (30:9:25:6:18, v/v/v/v/v) as mobile phase (Touchstone et al. 
1980). The plates were dried and the spots visualized under UV light (254 nm) after 
spraying the plates with 0.01 % Rhodamine 6G in distilled water. The spots were scraped 
off the plates and their percentages were calculated on the basis of phosphorus 
determinations. 
Suljactant Protein A in bronchoalveolar lavage fluid 
To compare SP-A contents in lavage fluid from fetal Nitrofen-exposed and control rats a 
dot blot assay was performed. For this purpose lavage fluid was centrifuged for I hr at 
20,000g. The pellets were resuspended in 0.9% NaCl; the final volumes were adjusted 
with 0.9% NaCI to obtain equal concentrations of phospholipid in lavage material from 
Nitrofen-exposed and control rats. Drops with predetermined concentrations of 
phospholipid were spotted on nitrocellulose paper. After drying, the blots were incubated 
for three hours with I % bovine serum albumin (BSA) in phosphate buffered saline (PBS) 
and subsequently incubated overnight with our anti-SP-A antiserum (rabbit anti-mouse; 
1:400; Oomen et al., 1990) or with pre-immunization serum as a negative control. After 
rinsing 3x20 min with PBS the blots were incubated with SWAR-peroxidase (swine anti-
rabbit) conjugate for 90 min, rinsed again with PBS (3x20 min) and stained with diamino 
benzidine (DAB) in TRIS buffer (pH 7.4) for 1-15 min. The staining was stopped with 
0.4 % fi-mercapto-ethanol as soon as the staining visually was considered to be optimal. 
Finally the blots were rinsed with distilled water and dried overnight on filtration paper. 
Bronchoalveolar lavage fluid from patients with alveolar proteinosis was used as a positive 
control, and normal human, mouse, and rat serum as negative controls. 
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3.4 Results 
Light microscopy 
In general, lung development in Nitrofen-exposed and control rats followed the pathway 
proposed for mammals (Fig. 1). On day 19 (not shown), control and exposed lungs looked 
similar and were at the pseudoglandular stage of lung development. The prospective 
pulmonary acinus consisted of tubules with small round lumens, lined by approximately 
cuboid epithelial cells with large and roundish nuclei (acinar tubules with cuboid type II 
cells, see Fig. IB). Differences between Nitrofen-exposed and control lungs were present 
from day 20 onward and became more pronounced with time. On day 20 (canalicular 
stage, not illustrated), some tubules were slightly dilated and lined by cuboid and thinner 
cells; these tubules were less numerous in exposed lungs. On days 21 and 22, control and 
exposed lungs were in the saccular stage of lung development (Fig. 2A,B). The saccular 
lining consisted of some (low) cuboid cells interspersed with a few (day 21) or many (day 
22) thin cells in control lungs, and cuboid and low cuboid to thin cells in exposed lungs. 
In the exposed lungs, the lumens of air spaces were frequently slit-like, and acinar tubules 
were more abundant than in control lungs. These phenomena gave the exposed lungs a 
primitive, compact aspect compared to control lungs (Fig. 2). For further details, see 
Brandsma et a1. (1992a). 
Transmission Electron Microscopy 
On day 19 the acinar tubules of the respiratory system in control (Fig. 3A) and Nitrofen-
exposed (not shown) fetal rats were lined exclusively by low columnar or cuboid epithelial 
cells with large and roundish nuclei. These approximately cuboid cells contained large 
glycogen fields and a few inclusion bodies (IBs; Figs. 3B-D). Most of the lBs were 
cytoplasmic lBs (Fig. 3B) situated in or near a glycogen field. Cytoplasmic lBs usually 
contain glycogen particles, and are bounded by one or more membranes of smooth 
endoplasmic reticulum (ER); they probably are primary stages in prenatal multilamellar 
body (MLB) formation (Ten Have-Opbroek et al. 1990). In addition some dense bodies 
(DBs; Fig. 3B), osmiophilic multivesicular bodies (MVBs; Fig. 3C) and occasionally lBs 
with a few lamellae, so-called lamellar bodies (LBs; Ten Have-Opbroek 1990) were 
present (Fig. 3D). In exposed lungs (Fig. 3E) the findings were similar, except that some 
LBs had a higher electron density and confluent thick lamellae. 
In both groups the dilated acinar tubules on day 20 (Fig. 4A) were lined by cuboid cells, 
low cuboid cells with an extended basis, and some thinner cells. Cuboid and low cuboid 
cells still contained large glycogen fields, and the same types of lBs as on day 19, but 
more abundantly. In addition, mature MLBs were seen in cuboid cells. The thinner cells 
contained little or no glycogen and a few IBs; most of these lBs were cytoplasmic lBs, but 
DBs (Fig. 4B) and osmiophilic MVBs (Fig. 4C) were also seen. The future air spaces 
contained a few MLBs and some tubular myelin. In Nitrofen-exposed lungs, again, a 
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Figure 1 Diagrams of mammalian lung development (Ten Have-Opbroek, 1981) (AI The two lung 
buds arising from the primitive foregut (in the rat by day 11) develop into the primordial systems of 
the right and left lungs. The undifferentiated epithelium lining the primordial tubules is pseudostra-
lifted columnar. (B) The prospective bronchial system and the prospective respiratory system (unit: 
pulmonary acinus) differentiate from the primordial Jystem, in the rat by day J 6. The basic 
structure in pUlmonary acinus fonnation is the acinar tubule or sprout (lining: type II cells), 
Tran::.jormation of acinar tubules results in derivative structures (dilated tubules, saccules, alveoli), 
which contain not only cuboid type II cells in their lining, but also thinner (developing) type J cells 
(in the rat as of day 20). 
similar picture was seen but MLBs in (low) cuboid cells were not as abundant as in 
control lungs. 
On day 21 the lining of the saccules in lungs from both groups consisted of some cuboid 
and low cuboid cells and many thinner epithelial cells. In the cuboid cells approximately 
half of the lBs were estimated to be cytoplasmic lBs in both exposed and control lungs, 
the other half consisted of DBs, MVBs and MLBs. Many cuboid cells as well as low 
cuboid cells contained large glycogen fields. In many low cuboid cells MLBs were seen. 
The thinner epithelial cells frequently contained little glycogen and a single DB, but in 
some of these cells osmiophilic MVBs, cytoplasmatic IBs, or LBs (Fig. 4D) were present. 
The future air spaces of both Nitrofen-exposed and control lungs contained tubular myelin 
and MLBs. 
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Figure 2 Fetal rat lungs, day 22; 1 p1n Epon sections, Toluidine blue staining, 225x. (A) Control 
group, normal tenninal sac stage. (8) Nitrojen-exposed group, the lung has a very compact aspect. 
On day 22 (Fig. 5) many thin epithelial cells and some cuboid cells lined the saccules. In 
control lungs most cuboid cells (Fig. 5A) contained little or no glycogen, but some still 
had large glycogen fields. Many lBs were present; after random counting we estimated 
that about half of the lBs were MLBs, and the other half cytoplasmic lBs, MVBs and 
DBs. In cuboid cells in exposed lungs (Fig. 5B), generally more glycogen was seen. The 
thin epithelial cells in control and Nitrofen-exposed lungs were like those on day 21, but 
contained less lBs. MLBs and tubular myelin were present in the future air spaces (Fig. 
5C,D). 
Figure 3 Transmission electron microscopical (!EM) pictures of developing type II cells in control 
(a-d) and Nitrafen-exposed (e) fetal rat lungs; day 19. (Nu, nucleus; G, glycogen; M, mitochondri-
on; RER, raugh endoplasmic reticulum). (A) Acinar tubule lined by appraximately cuboid (type 11) 
cells with large and roundish nuclei and microvilli (mv). Note the large apical or basal glycogen 
fields and the presence of some electron dense inclusion bodies (lBs; arrows). For details, see b-d. 
2. 240x. (8) Cytoplasmic IBs (arrows), containing glycogen and surrounded by smooth membranes; 
these IBs presumably are primary stages in MLB formation. Glycogen is easily lost during tissue 
processing. A dense body (arrowhead), probably representing another stage in 1l1LB formation, is 
also present. J9.000x. (C) Osmiophilic MVBs (arrows), also postulated precursors in MLB 
formation, and some discrete (un)coated vesicles (thin arrows) in the proximity Of MVBs and 
glycogen. 19.000x. (D) Lamellar body surrounded by glycogen. 19.000x. (E) Lamellar body in a 
large glycogen field in a type 11 cell of a Nitrofen-exposed fetus. Note the high density and 
confluent thick lomellae (Cf d.). 26.000x. 
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Figure 4 rEM pictures of (from type II cells) developing type I cells in control fetal rat lungs 
(Nitro fen-exposed group not shown); days 20 and 21. (Nu, nucleus; G, glycogen). (A) A dilated 
acinar tubule, lined by cuboid type II cells (arrowheads), low cuboid cells with an extended basis 
(arrows), and some thinner cells (thin arrows), Large glycogen fields are above or below the 
nucleus in cuboid cells, and beside the nucleus in low cuboid cells. 1,1M. (8) In cytoplasmic 
processes oj thinner cells precursors of MLBs such as dense bodies (arrow) can be found. 26.000x. 
(e) An osmiophilic MVB present in a thinner cell. 26.000x. (D) A thinner cell, containing a dense 
body (arrow) and two lamellar bodies (arrowheads). 9.200x. 
In the Nitrofen-exposed group (Figs. 5B,D) 14 out of 15 fetuses (day 19-22) had "MLBs" 
with higher electron density and confluent thick lamellae, whereas in the control group 
(Figs. 5A,C,E) only 5 out of 13 fetuses (day 19-22) showed this picture. "MLBs" with 
such a rather unusual appearance were observed both intra- and extracellularly. However, 
extracellular "MLBs" were more obviously different (Figs. 5C,D). Within this abnormal-
looking extracellular material more or less normal tubular myelin was present. 
Figure 5 TEM pictures of more or less mature type II cells and extracellular MLBs in control 
(a,c,e) and Nitrofen-exposed (b,d) fetal rat lungs; day 22. (Nu, nucleus; G, glycogen). (A) Mature 
type II cells with some MLBs (arrows); glycogenflelds are frequently absent. 6.000x. (B) Nitrofen-
exposed fetal rat lung. Note the LB within the glycogen fleld (arrowhead) and the confluent thick 
lamellae of the other MLBs (arrows). 6.000x. (C) Extracellular MLBs and tubular myelin (arrow). 
9.000x. (D) Nitro/en-exposed group; extracellular MLBs with a rather unusual appearance, i.e. 
dense and confluent (Cf c). Some tubular myelin is present (arrow). 9.000x. (E) Control group; a 
large glycogen field and electron dense MLBs,' in some control lungs MLBs show confluent thick 
lamellae as well (arrowj). 6JX)Ox. 
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Phospholipids in bronchoalveolar lavage fluid 
In Nitrofen-exposed fetuses leakage of fluid from the lung during bronchoalveolar lavage 
occurred sooner than in control fetuses, and the infused volume was not easily recovered 
again. By this, broncholalveolar lavage fluid from Nitrofen-exposed lungs was difficult to 
compare quantitatively to that from control lungs. Anyhow, it yielded significantly lower 
amounts of phospholipids than lavage fluid from control lungs. However, the quantity of 
individual phospholipids expressed as percentages of the total amount (Table 1) did not 
show significant differences between Nitrofen-exposed and control lungs. 
Table 1 Phospho/ipidjractions in bronchoalveolar lavage fluid from Nitro/en-exposed and control 
fetal (day 22) rats. 
Phospholipids 
Total (nmol/fetus) 
Lysophosphatidylcholine (%) 
Sphingomyelin (%) 
Phosphatidylcholine (%) 
Phosphatidylinositol (%) 
Phosphatidylethanolamine (%) 
Phosphatidylglycerol (%) 
Other minor phospholipids (%) 
SP-A in bronchoalveolar lavage fluid 
Control 
(n=1O; 5 pools) 
129.1 ± 81.9 
0.0 ± 0.0 
2.1 ± 0.4 
81.0 ± 3.3 
2.7 ± 0.7 
1.5 ± 0.3 
7.7 ± 1.9 
1.5 ± 0.9 
Nitrofen 
(n = 13; 4 pools) 
39.3 ± 60.4 
0.1 ± 0.2 
2.0 ± 0.9 
82.5 ± 5.1 
2.1 ± 0.8 
1.1 ± 0.2 
7.8 ± 2.3 
1.9 ± 0.9 
Dot blot immunoassays with serial dilutions of bronchoalveolar lavage fluid from 
Nitrofen-exposed and control fetal rats (Fig. 6) showed no difference in SP-A-reactivity 
per nmol phospholipid. Thus, the relative amount of SP-A in the lavaged surfactant was 
the same in both groups. It showed a similar positive reactivity pattern as SP-A in 
bronchoalveolar lavage fluid from patients with alveolar proteinosis (Fig. 6). The controls 
(normal mouse, human, and rat serum) were negative (Fig. 6). 
3.5 Discussion 
Ultrastructure oj alveolar epithelial cells in hypoplastic lungs 
The epithelial cells that line the prospective pulmonary acinus in hypoplastic and control 
fetal rat lungs, have all the characteristics of (im)mature type II alveolar epithelial cells. 
These cells are low columnar to approximately cuboid in shape, and display a large and 
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Figure 6 Dot blot assay, incubated with anti-
SP-A antiserum (1 :4(0). Lanes 1-6: serial 
dilutions 1/10-1/320. Lane A: normal mause 
serum. B: nomal human serum. C: broncho-
alveolar lavage fluid (BAL; 1:5) from patients 
with alveolar proteinosis. D and E: BAL 
(pellet) from control rats. F and G: BAL 
(pellet) from Nitrojen-exposed rats. H: normal 
rat serum. Note similar staining patterns for 
BAL from control and Nitro/en-exposed rat 
fetuses. 
roundish nucleus, and frequently large glycogen fields in the apical or basal cell parts. As 
shown previously for the rat (Brandsma et al. 1992; Otto-Verberne and Ten Have-
Opbroek 1987), such cells also exhibit a cytoplasmic staining for SP-A, another distinctive 
criterium for type II cell recognition (Ten Have-Opbroek 1975, 1979). The same features 
have been described for fetal type II cells in the mouse (Ten Have-Opbroek 1975, 1979, 
1981), the human (Otto-Verberne et al. 1988), and the Rhesus monkey (Ten Have-
Opbroek and Plopper 1992). Our study also demonstrates that type II cells in hypoplastic 
and control fetal rat lungs contain a variety of IBs, namely cytoplasmic lBs, MVBs, DBs, 
LBs and MLBs. The former four lBs highly probably are precursory stages of MLBs (Ten 
Have-Opbroek 1988; Ten Have-Opbroek et al. 1990). Furthermore, we found a decrease 
in glycogen content during maturation. This finding is in line with earlier reports for 
several species that describe that maturation of type II cells goes along with a marked 
decrease in glycogen content and a concomitant increase in the number of lBs, particularly 
MLBs (Chi 1985; Kikkawa and Spitzer 1969; Ten Have-Opbroek et al. 1990). This course 
of events is not surprising, because glycogen may constitute a source of energy as well as 
a source of substrate for lipid bilayers of the cell. Evidence that in type II cells glycogen 
may also specifically provide substrates for the production of surfactant phospholipid 
biosynthesis has been obtained in biochemical studies performed in the developing rat lung 
(review: Batenburg 1992). 
A remarkable finding in our study is the existence of unusual looking "MLBs" 
characterized by a higher electron density and confluent thick lamellae. In the Nitrofen-
exposed group 14 out of IS fetuses show this picture, whereas in the control group only 5 
out of 13 fetuses do so. The reason for this phenomenon, not mentioned by other authors, 
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is not clear but suggests a qualitative difference in surfactant composition. Williams et al. 
(1991) show that changes in morphological appearance of surfactant phospholipids can be 
produced by adding SP-A to the lipid mixture. Therefore, we have included further 
research concerning surfactant composition (see below). 
Besides cuboid type II cells, hypoplastic and control fetal rat lungs also display lower cell 
types from day 20 onward. These cells must represent from type II cells developing type I 
cells with intermediate characteristics (Adamson and Bowden 1975; Brandsma et a1. 
1992b; Ten Have-Opbroek 1981, 1991). The developing type I cells occur in various 
forms, i.e., as low cuboid cells with an extended basis or as thinner cells; both forms 
contain precursory stages of MLBs and frequently Jarge glycogen fields. Initially, these 
glycogen fields are predominantly located in the lateral cytoplasmic compartments. Further 
attenuation of these cells goes along with a further decrease in IE and glycogen content. 
Very thin cells, i.e. mature type I cells seen on day 22, lack IEs and glycogen. There are 
no ultrastructural differences between developing or mature type I cells in hypoplastic and 
control lungs. 
In summary, the major differences between hypoplastic and control fetal rat lungs are that 
there are less mature MLBs on day 20 and more glycogen on day 22 in type II cells of 
hypoplastic lungs, suggesting that these cells in hypoplastic lungs are retarded in 
maturation compared to those in control lungs. In a former study (Brandsma et a1. 1992a) 
we showed that Nitrofen-exposed hypoplastic fetal rat lungs are retarded with respect to 
the differentiation of type II into type I cells, based on immunofluorescence reactivity for 
SP-A. Apparently, the maturation of immature type II cells to mature type II cells is 
retarded as well. This finding suggests that the degree of maturity of type II cells may 
playa role in type I cell differentiation. 
Only a few other electron microscopical studies have been performed, using the rat model 
for CDH and pulmonary hypoplasia. Kimbrough et aI. (1974) report no ultrastructural 
abnormalities of epithelial cells in hypoplastic lungs of newborn rats. However) in an 
abstract of the same group (Kimbrough et a1. 1973) poor expansion of the lungs in 
combination with less well developed LBs is mentioned. We have also found retardation 
of development of the future air spaces in lungs from Nitrofen-exposed fetuses (Brandsma 
et a!. I 992a). From their (Kimbrough et a1. 1973) results it is not clear whether the less 
well developed LBs are immature or abnormally formed LBs, as we have found in the 
present study. Studies in the fetal lamb model for CDH and pulmonary hypoplasia, in 
which CDH is created surgically during the pseudoglandular phase of lung development 
(Hashimoto et aI. 1985; Pringle 1989), mention an abundance of mature type II cells, 
based on the presence of mature MLBs. On the other hand, in the fetal lamb model in 
which pulmonary hypoplasia is achieved by phrenic nerve section (Nagai et a1. 1988) 
much more glycogen and a significantly smaller number of LBs have been found in type II 
cells. Thus, according to this study, there is an abundance of immature type II cells. In 
human lungs from children with CDH one study (Nakamura et aI. 1991) also describes a 
ULTRASTRUCTURAL FEATURES 57 
reduced number of LBs in type II cells in the affected lungs in four out of five cases 
examined. 
In short, data in the literature on ultrastructural differences between alveolar epithelial 
cells in hypoplastic and control lungs are scarce and contradictory. We conclude from the 
studies in our fetal rat model of pulmonary hypoplasia and CDH that both categories of 
lungs display similar ultrastructural features, although with an apparently different time 
scale and abundance, as a result of which hypoplastic lungs look less mature near term 
than control lungs. 
Suifactant - phospholipids and SP-A - in hypoplastic lungs 
In view of our finding of abnormal looking "MLBs" we have measured phospholipid 
fractions and SP-A-content in bronchoalveolar lavage fluid from Nitrofen-exposed and 
control animals. The same amount of SP-A per mol phospholipid appears to be present in 
both groups. The same holds for the relative amounts of phospholipid components: there 
is no difference between the Nitrofen-exposed group and the control group. The 
phospholipid composition in bronchoalveolar lavage fluid from these groups is roughly the 
same as described for normal newborn, young, and adult rats (Egberts et al. 1992). 
However, the total amount of phospholipid (nmol) recovered from Nitrofen-exposed rat 
fetuses by bronchoalveolar lavage is significantly less than that recovered from control 
rats. In our opinion, this does not prove that these Nitrofen-exposed hypoplastic fetal rat 
lungs are surfactant deficient. Electron microscopically, no obvious difference is 
observable in the abundance of intra- and extracellular MLBs between Nitrofen-exposed 
and control lungs on day 22. Very likely, the difference found in total amounts of 
phospholipid is largely due to a difference in bronchoalveolar lavage efficiency, because 
hypoplastic lungs could not be washed as efficiently as normal lungs. Another factor could 
be the difference in weight between hypoplastic and control lungs. Therefore, correction 
of the total amount of phospholipids for lung weight may reduce the diverging results. 
Bronchoalveolar lavage is a good method to obtain material from normal and hypoplastic 
lungs for qualitative analysis of phospholipids and proteins. For quantitative 
measurements, whole lung homogenates or preferably, MLB-content may be more suitable 
materials. 
Findings on surfactant synthesis from former studies using the rat model (Kavlock et al. 
1982; Kimbrough et al. 1973; Stone and Manson 1981; Suen et al. 1992; Tovar et al. 
1992) are divergent. Kavlock et al. (1982), Kimbrough et al. (1973) and Suen et al. 
(1992) suggest a decrease in surfactant synthesis, Stone and Manson (1981) find no effect 
of Nitrofen, while Tovar et al. (1992) describe an increase in surfactant synthesis. 
Kavlock et al. (1982) mention decreased total dipalmitoyl phosphatidylcholine (DPC) per 
lung and decreased total sphingomyelin (SPH) per lung on day 21 after Nitrafen exposure. 
From these results it is not clear whether DPC and SPH per mg lung tissue are decreased 
as well. Suen et al. (1992) has studied two Nitrofen-exposed groups on day 21: one with 
58 CHAPTER 3 
and one without a defect in the diaphragm. They have found less disaturated 
phosphatidylcholine per lung and per I'g DNA in the CDH group than in the group 
without CDH. On the other hand, Stone and Manson (1981) have found no difference in 
14C-choline uptake, cholinephosphotransferase activity and phospholipids per mg lung 
tissue between Nitrofen-exposed and control fetuses on days 20 and 21. Tovar et aI. 
(1992) have even found increased levels of PC, PG and PIon day 21 in Nitrofen-exposed 
fetuses, compared to normal controls. In summary, the findings on surfactant-synthesis in 
hypoplastic rat lungs are not uniform at all. In general, in most studies surfactant synthesis 
is found to be either not affected or decreased after Nitrofen exposure. Only one study 
(Tovar et al. 1992) describes an increase in surfactant synthesis. 
A similar controversy can be observed in other animal models for pulmonary hypoplasia, 
and in humans. Using the fetal lamb model for CDH and pulmonary hypoplasia, only one 
study documents the status of the surfactant system (Glick et al. 1992) and mentions 
decreased total phospholipids and increased proteins per g lung tissue. In addition, the 
relative amounts of different phospholipid components is said to be altered; the proportion 
of PC is significantly reduced, whereas that of LPC and PI are significantly increased. 
These findings are not confirmed by the present study. In hypoplastic rat lungs associated 
with oligohydramnion (Blachford and Thurlbeck 1987) reduced amounts of phospholipid 
per lung have been found on day 21, whereas the amount per mg dry lung weight is the 
same as in normal control lungs. In experiments with lungs made hypoplastic by cervical 
spinal cordotomy or phrenic nerve section (Kitterman 1984) no difference has been found 
in DSPC concentration in lung tissue or lung lavage fluid. Human case studies report 
decreased LIS ratios in amniotic fluid (Berk and Grundy 1982; Hisanaga et al. 1984) as 
well as decreased phospholipids per I'g DNA (Blackburn et al. 1977; Nakamura et aI. 
1991; Wigglesworth et al. 1981). Small clinical trials of surfactant instillation (either 
prophylactic, or therapeutic; Bos et al. 1991; Glick et al. 1991; Lotze et al. 1993) show 
varying results. 
From the results in our model for pulmonary hypoplasia and CDH, we conclude that in 
hypoplastic fetal rat lungs type II cells are less mature than in contro11ungs; nevertheless, 
the composition of extracellular surfactant is likely the same. 
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THE NATURAL mSTORY OF CONGENITAL 
DIAPHRAGMATIC HERNIA AND PULMONARY HYPOPLASIA 
IN THE EMBRYO 
4.1 Abstract 
Up to now, descriptions of the natural history of congenital diaphragmatic hernia 
(CD H) associated with pulmonary hypoplasia are based exclusively on observations made 
in the fetal period. However, nothing is known about the events that take place in an 
embryo with CDH. Recently, an animal model of CDH and PH has been established in rat 
embryos to study the embryology and natural history of this lesion. We exposed 36 
pregnant Sprague-Dawley rats to a single dose of 100 mg Nitrofen on day 11 of 
pregnancy. A total of 356 staged embryos and fetuses from day 13 to day 21 were studied 
by light and scanning electron microscopy. The litters of 9 untreated rats (124 normal age-
matched embryos and fetuses) served as controls. The abnormal development of the 
diaphragmatic anlage was first seen in embryos aged 13 to 14 days. A defect appeared in 
the dorsal part of the diaphragm, normally on the right side. The liver grew through this 
defect early on. Gut was found in an intrathoracic position only in the very late stages 
(day 21/22) and newborns. Compared to controls, lungs of Nitrofen-exposed embryos with 
CDR were smaller, depending on the size of liver found in the thoracic cavity. 
Histologically, compression of lung was absent at these stages. Most authors speculate that 
CDH results because the pleuroperitoneal canals fail to close at the end of the embryonic 
period (i.e. week 8 to 10 in human development) leading to a defect in the dorsolateral 
region of the diaphragm. However, contradictory to this assumption, our findings indicate 
that diaphragmatic defects develop in early embryonic life. They are easy to identify even 
in rat embryos as early as 14 days. The early ingrowth of liver into the thoracic cavity 
through these defects is the crucial step in the pathogenesis of pulmonary hypoplasia in 
CDH, because it is the liver and not the gut that reduces the thoracic cavity in the 
embryo. Normal lung growth will be hampered in early embryonic stages according to the 
size of the liver mass inside the thoracic cavity. Recent reports suggest that the presence 
of liver in the fetal thoracic cavity affects the outcome of a fetus with CDH. This 
observation is in accordance with our findings, suggesting that the major events of 
pathogenesis take pJace in the embryo and not in the fetus, as often assumed. 
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4.2 Introduction 
The outcome of a newborn with congenital diaphragmatic hernia (CDH) depends on the 
severity of the associated pulmonary hypoplasia. Most authors consider lung hypoplasia as 
a secondary abnormality: delayed or incomplete closure of the so-called pleuroperitoneal 
canals may result in the herniation of intestine into the thoracic cavity leading to abnormal 
compression of the developing lungs (Gray and Skandalakis 1972; Wells 1954). Studies on 
the natural history of CDH in humans and data derived from experimental animal models 
(Adzick et al. 1985; DeLorimier et al. 1976; Harrison et al. 1980a and 1980b) seem to 
support this assumption. These studies, however, are based exclusively on observations 
made in the fetal period while data that may elucidate the natural history of CDH in the 
embryonic period are not at hand. An animal model of CDH and pulmonary hypoplasia 
has been recently established in rat embryos using Nitrofen (2,4-dichlorophenyl-p-nitro 
phenyl ether) as teratogen (Kluth et al. 1990; Tenbrinck et al. 1990). We used this model 
to define the specific morphological changes of CDH and pulmonary hypoplasia during the 
embryogenesis of this lesion. 
4.3 Materials and Methods 
Adult female Sprague-Dawley rats weighing between 196 and 319 g (mean: 261 g), 
were bred under normal laboratory conditions. After controlled overnight mating, 
pregnancy was verified by means of the vaginal smear method. The day of positive smear 
was rated as day zero of pregnancy. The pregnant rats were exposed to a single dose (100 
mg/rat) of orally administered Nitrofen (Wako Chemicals, Neuss, Germany) on day 11 of 
pregnancy. The substance was mixed with 20 g of moistened commercial rat chow 
(Altromin, Lage, Germany) and offered to the rats after a 24-h period of fasting. Rats not 
consuming the mixture within 12 hours were excluded. Using this method, 36 pregnant 
rats could be exposed successfully to Nitrofen. Thereafter the rats were again supplied 
with food and water ad libitum. Nine other rats, also undergoing a 24-hour fast, served as 
controls. 
Four rats from the Nitrofen group plus one control rat were killed on each day between 
day 13 and 21 of pregnancy. A total of 480 embryos and fetuses (356 from the Nitrofen 
group, 124 controls) were removed by laparotomy and were then staged after Witschi 
(1962). One litter from each treated group and three embryos from each control rat (92 
Nitrofen embryos plus 27 control embryos) were fixed in Bouin, embedded in paraffin, 
cut in serial sections (7 J£rn) and stained with hematoxilin-eosin for light microscopy 
(LM). 
The remaining embryos and fetuses (264 Nitrofen embryos and 97 control embryos) were 
fixed in glutaraldehyde for 24 hours and then microdissected in 80% ethanol. After 
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dehydratation, the embryos were dried by critical point method, gold-sputtered, and then 
examined and photographed with a DMS 940 scanning electron microscope (SEM) 
(C.Zeiss, Oberkochen, Germany). 
4.4 Results 
SEM findings 
In the first group (13 days) a total of 30 Nitrafen embryos and 5 embryos of the control 
group were studied. No deviation in the morphology of the diaphragm was found, when 
we compared the Nitrofen group with the control group. Furthermore, we found no 
differences between the Nitrofen group and the control animals when we studied the 
development of the lungs at this stage (Fig. I). 
In the second group (14 days) a total of 41 Nitrofen embryos and 4 controls were 
analyzed. In this age group there was clear evidence of disturbed diaphragmatic 
development in the embryos of the Nitrofen group while evidence of disturbed lung 
development was absent. In the majority of these embryos, a defect was found in the 
dorsal part of the diaphragm (Fig. 2A). All defects appeared exclusively on the right side. 
They resulted in an abnormal diaphragm. leaving parts of the liver uncovered. Compared 
to controls, the left dorsal. diaphragm was found to be normal in all studied embryos.!n 
the next two age groups (15 days and 16 days) 34 and 32 Nitrafen embryos and 7 and 6 
Figure 1 SEM pictures of a 13~day-old rat embryo. This stage corresponds to a human embryo 5 
weeks of age. (Li, liver; St, stomach; Uu, left lung; RLu, right lung). (A) Dorsal view. The lungs 
are still in situ. (B) Dorsal view into the right thoracic cavity. The right lung is removed. Arrows 
indicate the lower border of the diaphragm. 
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Figure 2 SEM 
pictures of rat 
embryos. These 
stages correspond 
to a human 
embryo 5 to 6 
weeks of age. 
(A) 14-Day-old 
Nitro/en-exposed 
ral embryo. 
Dorsal view. The 
lungs are 
removed. The left 
pleuroperitoneal 
opening (LPO) is 
normal. A large 
defect is seen in 
the right dia-
phragm (black 
arrows). The 
diaphragm ends 
abnormally high, 
leaving palts of 
the liver 
oncovered. 
(E) 13.5-Day-old 
rat embryo 
(control group). 
Black arrows 
indicate the 
border of the 
normally 
developed 
diaphragm. White 
arrows indicate 
the site of this 
border in a 13-
day-old embryo. 
The downgrowth 
qf the diaphragm 
is notable. (lCV, 
inferior vena 
cava). 
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Figure 3 SEM pictures 
of 16-day-old Nitrofen-
exposed rat embryos. 
This stage corresponds 
to a human embryo 7 
weeks of age. (Li, liver; 
Lu, lung; Dr, 
diaphragm). 
(A) Lateral view. A 
small part of the liver 
protrudes through the 
diaphragmatic defect 
and is now inside the 
thoracic cavity. Note the 
close contact between 
liver and lung. 
(8) Dorsal view. The 
right lung is partially 
removed. The large 
defect with the 
intrathoracally displaced 
portion of the liver is 
seen. Due to the 
ingro'vVth of liver, the 
opening of the right 
pleuroperitoneal "canal" 
fails to close (arrow). 
Note that this opening 
represents only a small 
part of the whole defect. 
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Figure 4 SEM pictures of diaphragmatic defects. This stage corre~ponds to a human embryo 8 
weeks of age. (lCV, inferior vena cava). (A) A small defect. Typically, this is in close contact with 
the inferior vena cava and is thus more centrally located. The white arrow indicates the region 
where the opening of the right pleuroperitoneal "canal" has closed. (B) A large deject. This defect 
incorporates the dorsolateral region (Bochdalek type). 
age-matched controls were studied. In most litters, the majority of embryos had a right 
diaphragmatic defect. In all these embryos, the liver was clearly seen inside the thoracic 
cavity (Fig. 3A). Two distinct forms of the malformation could be discerned. Typically, a 
minor form of the defect was found centrally, close to the inferior vena cava (Fig. 4A). In 
these cases the so-called pleuroperitonea! canals closed properly. In the major form (Fig. 
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Figure 5 SEM 
picture of a IS-day-
old Nitrofen-exposed 
rat embryo. This 
stage corresponds to 
a human embryo 10 
weeks of age. View 
from dorsal. The 
liver (Li) occupies 
nearly one third oj 
the thoracic cavity. 
The right lung is 
reduced in size. 
Bowel loops are 
absent. 
4B), the defect extended from the inferior vena cava to the dorsolateral region of the 
diaphragm, thus incorporating the openings of the pleuroperitoneal "canals". In these age 
groups, the gross aspect of the lungs appeared to be normal. The lungs often covered the 
diaphragmatic defect, making it difficult to detect. However, after removing the lungs, the 
total extend of the defect became apparent (Fig. 3B). In all normal 16-day-old embryos, 
the openings of the pleuropedtoneal "canals" were found to be closed on the dght and left 
side of the diaphragm. At this stage, bowel loops were still found exclusively inside the 
extraembryonic celom of the umbilicus. 
In the following two age groups (17 days and 18 days) 28 and 25 Nitrofen embryos were 
compared with 7 and 8 controls. There was a remarkable difference in the growth pattern 
of the more "central" defects (minor forms) and the "dorsolateral" defects (major forms). 
In some of the embryos with a major defect, the liver occupied one third of the thoracic 
cavity (Fig. 5). In these cases, right lungs were markedly reduced in size compared to 
normal controls. In the minor defects, only a small portion of the liver reached the thorax. 
In these cases, the lungs were nearly normal except for a small indentation in the area of 
the protruding liver. In all IS-day embryos, the intestine was found inside the abdominal 
cavity while in the embryos of the 17-day age group, intestinal loops remained still in the 
extraembryonic celomic cavity of the umbilicus. 
NATURAL HISTORY 71 
Figure 6 SEM pictures 
of Nitrojen-exposed rat 
fetuses, These stages 
correspond to human 
fetuses older than 18 
weeks. (Li, liver,' BL, 
bowel loops; Lu, lung). 
(A) 20-Day-old jetus. 
Half oj the thoracic 
cavity is occupied by 
liver. The lung is 
markedly reduced. 
Bowel loops are still 
absent. 
(B) 21-Day-old jetus. 
Bowel loops finally have 
entered the thoracic 
cavity. The liver 
occupies two thirds of 
the thoracic caVity. The 
lung is small. 
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Figure 7 LM pictures of serial sections of 18~day-old rat embryos. This stage corresponds to a 
human embryo 10 weeks of age. (Li, liver; Lu, lung; Di, diaphragm). (A) Control embryo. (B) 
Nitro/en-exposed embryo. Clear signs of lung compression by the ingrowing liver can not be 
discerned. 
The next age groups (19 days, 20 days, and 21days) represent the fetal stage of 
development. Here, the whole spectrum of the malformation could be observed. In some 
of the 19- and 20-day-old rat fetuses, over half of the chest was occupied by liver masses 
(Fig. 6A), while in others the ingrowth of the liver was less obvious. In those with 
massive liver protrusion, the lungs were small and hypoplastic while they appeared nearly 
normal when only small parts of liver were found inside the chest. Intrathoracally 
displaced bowel loops were first observed in 21-day-old fetuses (Fig. 6B). In these, the 
lungs were found to be reduced in size due to amount of liver occupying up to two thirds 
of the available thoracic space. 
LMfindings 
Our anatomical SEM findings were confirmed by serial histological sections. The defect 
was first identified in IS-day-old embryos. It was always situated in the dorsal diaphragm 
and was found in close contact with the inferior vena cava. Starting on day 16, the liver 
gradually expanded into the thoracic cavity. However, clear signs of lung compression 
were not found in our embryos (Fig. 7). Comparison of the lungs and the thoracic cavities 
in age groups 16 and 18 demonstrated that in the embryo, these structures were expanding 
despite the ingrowth of liver (Fig. 8). 
16d 
4.5 Discussion 
18d 
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Figure 8 "When two 
embryos of different 
age groups are 
compared (16 days 
versus 18 days), the 
expansion of the 
thoracic cavity 
becomes obvious, 
Thus, the lung still 
continues to grow, 
while part of the 
chest is occupied by 
liver. In a growing 
embryonic body, 
compression is 
unlikely. (Sketch after 
serial sections in 
same magnification). 
Since Broman's investigations (1902) on the diaphragmatic development, most authors 
have speculated that CDH results because the pleuroperitoneal canals fail to close at the 
end of the embryonic period (i.e. week 8 to 10 in human development) leading to a defect 
in the dorsolateral region of the diaphragm (Gray and Skandalakis 1972; Harrison 1990; 
Wells 1954). Bowel loops may then herniate through this defect into the chest with 
subsequent hypoplasia of the developing fetal lungs (Gray and Skandalakis 1972; Harrison 
1990; Wells 1954). However, the natural history of this sequence of embryological and 
fetal events has not been previously studied. Thus, the pathogenesis of the CDH and the 
associated pulmonary hypoplasia is still elusive and the answers to the following questions 
remain unknown: (I) When does the diaphragmatic defect appear? (2) Are the 
pleuroperitonea! canals the precursors of the diaphragmatic defect? (3) Why is the lung 
hypoplastic in cases of CDH? 
Since 1971, the embryotoxicity of the herbicide Nitrofen (2,4-dichlorophenyl-p-nitro-
phenyl ether) is well known (Ambrose et a!. 1971). In 1981, Nakao et al. noticed that this 
teratogen can induce CDH in rats and mice. Since then, this substance has been widely 
used to study its effect on the lung and diaphragm (Iritani 1984; Nakao and Ueki 1987; 
Ueki et a!. 1990). However, only the work of Iritani (1984) adresses the natural history of 
CDH in the embryo. In our study, we used the pulse feeding technique. Pregnant rats 
were exposed to a single 100-mg dose of Nitrofen on day 11 of pregnancy. This day has 
been previously identified by us to be highly sensitive to the teratogenetic effect of 
Nitrofen (Kluth et a!. 1990; Tenbrinck et al. 1990). 
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The onset of CDH 
Most authors speculate that in the human fetus with CDH, the pleuroperitoneal canals fail 
to close late in the embryonic period between the 8th and 10th week of gestation (Gray 
and Skandalakis 1972; Harrison 1990; Wells 1954). At the same time, the intestine returns 
into the abdominal cavity (Gray and Skandalakis 1972; Harrison 1990; Starck 1975; Wells 
1954). In rats, this developmental stage is equivalent to that of 17 or 18 days of gestation. 
At this time, the openings of the so-called pleuroperitoneal canals are normally closed 
(Kluth et al. 1989). 
In contrast to this assumption, it is evident from our study that the diaphragm is already 
malformed in the 14-day-old embryo (Fig. 2A). This age group is equivalent to that of a 
5- to 6-week-old human embryo. In a 13-day-old rat embryo, signs of a disturbed 
diaphragmatic development are still missing (Fig. lB). However, the onset of the 
malformation takes place at this stage. The diaphragmatic anlage of a 13.5-day-old 
embryo (Fig. 2B) is too advanced to serve as the starting point for the maldevelopment. 
These findings are in accordance with observations made by Iritani (1984). He found signs 
of disturbed diaphragmatic development in II-day-old mouse embryos exposed to Nitrofen 
continuously from day 5 to II after conception. Thus, we conclude that in rat embryos the 
onset of the diaphragmatic defect clearly lies in the early embryonic period. This phase is 
comparable to that of a human embryo in the 5th gestational week. 
The site qf the defect 
Iritani (1984) was the first to notice that Nitrofen-induced diaphragmatic hernias are not 
caused by an improper closure of the pleuroperitoneal openings but rather the result of a 
defective development of the so-called posthepatic mesenchymal plate (PHMP). 
The observed defects were also localized in the PHMP in our SEM study (Fig. 2A). We 
could identify two distinct types of defects: (1) large "dorsolateral" defects and (2) small 
"central" defects. Large defects extended into the region of the pleuroperitonea! openings. 
In these cases, the closure of the pleuroperitonea! openings was usually impaired by the 
massive ingrowth of liver (Fig. 3B). If the defects were small, they were consistantly 
isolated from the pleuroperitonea! openings closing normally at the 16th or 17th day of 
gestation. Thus, in our embryos with CDH, the region of the diaphragmatic defect was a 
distinct entity and was seperated from that part of the diaphragm where the 
pleuroperitoneal "canals" are localized. We conclude therefore that the pleuroperitonea! 
openings are not the precursors of the diaphragmatic defect. 
The lung in CDH: 
Primary pulmonary hypoplasia 
Nakao et al (1987), Ueki et al (1990) and Iritani (1984) postulated that the lung is 
primarily hypoplastic. In his study, Iritani even drew the conclusion that the hypoplastic 
lung may induce a defective PHMP which may again result in CDH (Iritani 1984). 
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However, in our young embryos (14 days gestational age) with a diaphragmatic defect, 
disorders of the early lung anlage could not be observed. This finding is in sharp contrast 
to previously published results by Ueki et al. (1990). They observed reduced lung growth 
in young mouse embryos continuously exposed to Nitrofen from postconceptual days 5 to 
II. However, this reduced lung growth may be the result of Nitrofen interference with the 
very early lung anlage. It is well known that developing embryonic organs have specific 
periods of greatest sensitivity to teratogens. Continuous administration of Nitrofen for a 
longer period must thus result in a combination of malformations. In our study, we 
avoided this combination by pulse feeding of Nitrofen on day II. The diaphragm has 
proved to be highly sensitive to the teratogenetic action of Nitrofen on this day (Kluth et 
al. 1990; Tenbrinck et al. 1990). 
Secondary pulmonary hypoplasia 
It is generally assumed in the literature, that lung hypoplasia in cases of CDH is of 
secondary origin (Gray and Skandalakis 1972; Harrison 1990; Harrison et al. 1980a and 
1980b; Wells 1954) and that this hypoplasia is caused by herniated bowel loops 
compressing the developing fetal lung (Harrison 1990). In contrast to this assumption, our 
study indicates that pulmonary hypoplasia develops in the embryonic period. Soon after 
the onset of the defect in the 14-day-old embryo, liver grows through the diaphragmatic 
defect into the thoracic cavity. This indicates that from this time on the available thoracic 
space is reduced and further lung growth hampered. In 15- or 16-day-old embryos, the 
amount of liver inside the chest is only small (Fig. 3A). Therefore, the lungs are nearly 
normal in these age groups. However, in embryos aged 17 or 18 days, more than one 
third of available thoracic space may be occupied by liver masses. In these cases, the 
impaired lung growth is obvious. At first sight, in our embryos pulmonary hypoplasia 
seems to be the result of compression caused by the ingrowing liver. However, serial 
section analysis reveals that clear signs of lung compression are absent (Fig. 7). 
Furthermore, it is obvious (Fig. 8) that in the embryo, the thoracic cavity expands despite 
the ingrowth of liver. Lung compression is therefore unlikely in a fast growing embryo. 
Herniated gut was found in our embryos and fetuses only in late stages of development 
(21 days and newborns). In all of these, the lungs were already hypoplastic, when the 
bowel entered the thoracic cavity (Fig. 6B). Based on our observations, we conclude that 
the early ingrowth of the liver through the diaphragmatic defect is the crucial step in the 
pathogenesis of pulmonary hypoplasia in CDH. The presence of liver inside the fetal 
thoracic cavity was recently considered to be of major prognostic importance in the 
outcome of a fetus with CDH (Harrison et al. 1990). Our pathogenetic concept clearly 
explains this observation. We found that impaired lung development is proportional to the 
size of the liver mass inside the thoracic cavity. This indicates that growth impairment is 
not the result of lung compression in the fetus but rather the result of growth competition 
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in the embryo: the liver that grows faster than the lung reduces the available thoracic 
space. If the remaining space is too small, pulmonary hypoplasia will result. 
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PROLIFERATION AND DIFFERENTIATION IN EARLY FETAL 
RAT LUNGS 
A light microscopical and immunohistochemical study in a rat model of 
pulmonary hypoplasia and congenital diaphragmatic hernia 
5.1 Summary 
The aim of this study was to investigate the effect of 2,4-dichlorophenyl-p-
nitrophenylether (Nitrofen) on early fetal lung development, and to distinguish between 
effects on proliferation and effects on differentiation of the lung primordium. Pregnant 
rats were exposed by gavage to Nitrofen (400 mg/kg body weight on day 10 of gestation). 
Fetuses were collected by Caesarean section on days 11, 12, 13, 15, 17, and 21 (birth on 
day 23); fetuses or their lungs were embedded in paraffin and sectioned. As criteria for 
proliferation were taken measurements of length of the pulmonary primordium and 
staining for PCNA. As differentiation markers we used antibodies against the collagens III 
and IV, fibronectin, and laminin. Measurements of length showed that the early growth of 
the lung primordium was reduced on day 13 after exposure to Nitrofen. No differences 
between normal fetal rat lungs and Nitrofen-exposed fetal rat lungs were found using the 
other markers. 
5.2 Introduction 
Lung hypoplasia is an important cause of neonatal mortality in man. It occurs isolated, 
or in conjunction with other anomalies, such as hydrops fetalis, renal anomalies, hernias 
(including congenital diaphragmatic hernia and omphalocele), skeletal anomalies, and 
abnormalities of amniotic fluid, e.g. oligohydramnios and polyhydramnios (Nakamura et 
al. 1992). In the case of congenital diaphragmatic hernia (CDH), the mortality rate 
(±50%) mainly depends on the gravity of pulmonary hypoplasia. 
To study pulmonary development in CDH we used a rat model: administration of the 
herbicide 2,4-dichlorophenyl-p-nitrophenyl (Nitrofen) to the mother on day 10 of 
pregnancy with resulting CDH and pulmonary hypoplasia in 80% of the offspring. 
Previous studies using this model have shown that Nitrofen-exposed, and thus hypoplastic, 
late fetal rat lungs are retarded with respect to the differentiation of cuboid type II cells 
into squamous type I cells whether or not CDH is present, and with respect to the 
development of the future air spaces between days 20 and 22 if CDH is present (Brandsma 
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et al. 1994b). However, an obvious effect of this retardation on the composition of 
extracellular surfactant obtained by bronchoalveolar lavage could not be demonstrated 
(Brandsma et aI. 1993). 
A scanning electron microscopical study performed by Kluth et aI. (1993) suggests that 
the early ingrowth of the liver into the thoracic cavity through the diaphragmatic defect 
may be crucial in the pathogenesis of pulmonary hypoplasia in CDH by reduction of the 
available thoracic space. 
Because of the similarity in stereochemical structure between Nitrofen and thyroid 
hormones, and the known trophic effect of thyroid hormones on lung development, 
Manson (1986) hypothesized that Nitrofen exposure has a thyreomimelic effect on the 
conceptus. This author suggested that this effect would be manifested as a transient 
stimulation of lung differentiation at the expense of lung growth. The results of our own 
study concerning the effect of Nitrofen on the binding of thyroid hormone to its receptor 
(Brandsma et aI. 1994c), rather indicate a thyreoslatic challenge to the conceptus resulting 
in retarded differentiation of alveolar epithelial cells and decreased growth of the lungs. 
The aim of the present study was to differentiate between those two theories by 
investigating the effect of Nitrofen on early fetal lung development, and to distinguish 
between effects on proliferation and effects on differentiation of the lung primordium. 
5.3 Materials and Methods 
Tissues 
Pulmonary hypoplasia in association with CDH was induced as described before (Kluth et 
al. 1990; Tenbrinck et aI. 1990): Specific pathogen free-derived adult rats (Riv:TOX, 
National Institute of Health and Environmental Protection -RIVM-, Bilthoven, The 
Netherlands) were mated (gestation day 0). On gestation day 10, a single dose of 400 
mg/kg body weight Nitrofen dissolved in olive oil was administered to the dams through 
an intragastric tube. Pregnant control animals received the same dose of olive oil without 
Nitrofen. Fetuses were collected by Caesarean section on days II, 12, 13, IS, 17, and 21 
(birth on day 23). In the youngest embryos the number of somites were counted and/or 
the crown-rump length was measured; of the older fetuses the body weight was 
determined; they were killed by decapitation. Presence, position and size of a 
diaphragmatic defect were evaluated if possible. Each litter was randomly subdivided into 
four groups. The fetuses of one of those groups (53 Nitrofen-exposed fetuses and 55 
control fetuses) were used in this study; they were fixed in 2% acetic acid in 100% 
ethanol, dehydrated in a graded alcohol series, and embedded in paraffin. 
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Antisera 
A monoclonal antibody against Proliferating Cell Nuclear Antigen (PCNA) was purchased 
from DAKO, Glostrup, Denmark, and was used at a dilution of I :750. At this dilution, 
about one third of the crypts in a section of adult rat intestines stained for PCNA. 
Affinity-purified goat antibody against type III collagen was obtained from Southern 
Biotechnology Associates, Inc., Birmingham, Alabama, and was used at a dilution of 
1:100. 
A monoclonal antibody against type IV collagen (M3F7) was purchased from the 
Developmental Studies Hybridoma Bank maintained by the Department of Pharmacology 
and Molecular Sciences, lohns Hopkins University School of Medicine, Baltimore, MD, 
and the Department of BiologicaJ Sciences, University of Iowa, Iowa City, lA, under 
contract NOI-HD-6-2915 from the NICHD. Anti-collagen IV was used at a dilution of 
1:50. 
Rabbit anti-fibronectin antiserum was a kind gift of Dr. B. Bachra, Sylvius Laboratory, 
Leiden, The Netherlands. The serum was used at a dilution of 1 :2000. 
Rabbit antiserum againts laminin obtained from E-Y Laboratories, Inc., San Mateo, 
California, was used at a dilution of 1:1000. 
Staining procedures 
The paraffin-embedded tissue was cut into sections of 5 I'm thickness. Some of these 
sections were stained with hematoxylin and eosin (H&E); these were used for light 
microscopicall investigation of lung growth and architecture of the pulmonary acinus. 
Adjacent sections were incubated with the above-mentioned antibodies. Prior to incubation 
the sections were deparaffinated in a graded alcohol series. Endogenous peroxidase 
activity was blocked with 0,3% H20 2 in phosphate buffered saline (PBS, pH 7.3); to 
reduce background staining the antibodies were diluted in PBS containing 0.1 % bovine 
serum a1bumine. Then the primary antibody was applied to the sections for overnight 
incubation, followed by incubation with the appropriate peroxidase-labelled secondary 
antibody for l'hh. After staining with the primary antibodies anti-collagen IV, anti-
laminin, and anti-PCNA, and the secondary antibodies, an additional peroxidase anti-
peroxidase (PAP, 1:500) was applied also for jI/2h to intensify staining results 
(Sternberger 1986). Each incubation was followed by rinsing with PBS (3x1O min). 
Subsequently the sections were stained with 0.04% diamino benzidine tetrahydrochloride 
(DAB) in 0.05M tris maleic acid (PH 7.6) with 0.006% H20 2 and either with or without 
0.05 % NiCl, for 5-10 min. The reaction was stopped with PBS and the sections were 
counterstained with methyl green or hematoxylin. 
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5.4 Results 
Proliferation 
Hematoxylin and eosin staininl?: The lung primordium was visible from day 12 of 
gestation, initially as an outgrowth of the bottom of the foregut, and on day 13 as a 
triplicate tube growing in caudal direction. The longitudinal growth speed of the lungs 
exceeded the growth of the whole embryo, resulting on day 15 in a longitudinal lung 
length of 20% of the embryo (Fig. 1). During this period the lung primordium consisted 
of tubules lined by (high) columnar primordial epithelial cells surrounded by mesenchymal 
tissue. The developing diaphragm could be seen from day 14 onward, and was still open 
on day 15. 
Exposure to Nitrofen on day 10 reduced the early growth of the lung primordium, as 
measured in serial longitudinal sections of exposed embryos on day 13 (Fig. 2). In 
Nitrofen-exposed fetuses that did not develop CDH, lung length had recovered to control 
range by day 21 (Fig. 3). In fetuses that did develop a diaphragmatic defect, which always 
occurred on the left side in this model, smaller left lungs were found in conjunction with 
right lungs that were significantly longer than control lungs (Fig. 3). 
PCNA: Anti-PCNA yields a nuclear staining pattern. On days 11, 12 (Fig. 4), and 13, 
approximately 100% of the epithelial cells of the foregut and the lung primordium stained 
for PCNA in both the control group and the Nitrofen-exposed group. On day 15, not all 
primordial epithelial cells in the lung were positive. Counting of the number of positive 
nuclei per volume of epithelial cells showed no difference between control lungs and lungs 
from the Nitrofen-exposed fetuses. On day 17, 95-100% of bronchial and alveolar 
epithelial cells stained for PCNA, while on day 21 only few positive cells were still seen 
in both groups. 
Also, there were no differences in PCNA-staining of mesenchymal cells between the 
control group and the Nitrofen-exposed group. 
Differentiation 
Collagen Ill: On day 11, no expression of collagen III in the foregut was observed. On 
day 12, a weak staining for collagen III was found underneath the epithelium of the 
lungbuds. On day 13, the staining became more intense; a sharp linear pattern surrounded 
the epithelium of the primordial tubules, and some staining was displayed in the 
mesenchyme. On days 15, 17 (Fig. 5) and 21, a similar staining pattern was found: a 
linear pattern around the (primordial) tubules, which could be very faint or very sharp, 
and in the mesenchyme, especially in the central parts of the lungs, the interlobar septa, 
and around large bronchi and vessels. 
There were no differences found in collagen III expression between control lungs and 
lungs from Nitrofen-exposed rats. 
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Figure 1 Length ~f the lung 
primordium in relation with crown-rump 
length (CRL) oj control rat embryos 
between days 11 and 15 of gestation. 
The growth of the lungs exceeds the 
growth of the whole embryo. 
Figure 2 Significant reduction of lung 
primordium length on day 13 oj 
gestation in rat embryos after Nitrofen~ 
exposure on day 10 oj gestation (n=4, 
p<O.05). 
Figure 3 Longitudinal Jetal lung 
diameter in relation with fetal body 
weight on day 21 in control and 
Nitro/en-exposed fetal rats. In the 
absence oj CDR, NitroJen-exposed 
fetuses are indistinguishable from 
controls, whereas in the presence oj 
CDR (always leftsided) left lungs are 
significantly shorter and right lungs are 
significantly longer than in control 
animals (n=44, 81, 37;p<O.05). 
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Figure 4 Fetal rat lung bud (LB; day 12), 
visible as an outgrowth of the foregut (FG), 
and stained/or PCNA. Approximately 100% 
of the epithelial cells are positive jor PCNA. 
16Ox. 
Collagen IV; On day 11, the basal lamina and the mesenchyme underneath the foregut 
epithelium expressed collagen IV. On days 12, 13, 15, 17 (Fig. 6), and 21, staining for 
collagen IV was found in the basal lamina around (primordial) tubules and blood vessels. 
Staining intensity varied; around tubules growing towards the pleura staining was often 
absent on days 15 and 17. 
No differences in collagen IV distribution were found between control lungs and lungs 
from Nitrofen-exposed rats. 
Fibronectin: On day 11, some staining for fibronectin was seen underneath the epithelium 
of the foregut. On days 12 and 13, staining was seen under the epithelium of the 
primordial tubules and in endothelial cells. On day 15 (Fig. 7), staining intensity around 
the tubules varied: underneath high columnar epithelial cells staining was much more 
intense than under low columnar to high cuboid cells. On day 17, this pattern was even 
more pronounced: under high columnar bronchial epithelial cells a thick layer of 
fibronectin was expressed, while under cuboid alveolar epithelial type II cells only a thin, 
sharp line was seen, Of, more peripherally, faint to no staining at all was found. 
Additionally, endothelial cells did stain and some mesenchymal staining was seen as well. 
On day 21, only endothelial and some mesenchymal staining was present. 
No differences in fibronectin expression were found between control lungs and lungs from 
Nitrofen-exposed rats. 
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Laminin: On day 11, the foregut epithelium displayed a cytoplasmic staining pattern. On 
days 12 and 13, the cytoplasm of primordial epithelial cells stained for laminin, and a 
sharp line was present underneath the epithelial cells. On day 15, a similar staining pattern 
was displayed, but with less intensity in the high columnar than in the low columnar 
epithelial cells. Also, endothelial cells stained for laminin. On days 17 (Fig. 8) and 21, no 
staining was found in columnar bronchial epithelial cells, while cuboid alveolar epithelial 
cells yielded a cytoplasmic staining pattern. 
Again, no differences were found between control lungs and lungs from Nitrofen-exposed 
rats. 
5.5 Discussion 
In 10 days, i.e. from day 12 of gestation to term, the rat lung develops from an 
epithelial protrusion of the foregut into a well differentiated organ with extensive 
perfusion and diffusion capacities. This requires tissue proliferation as well as 
differentiation. The epithelial outgrowth proliferates into two lung buds, which, by 
branching, each develop into a primordial tubular system within a matrix of mesenchyme. 
The tubules of this primordial system are lined by high columnar primordial epithelial 
cens on a basal lamina. Further ramification and differentiation leads to the formation of 
two functionally and morphologically distinctive entities: proximally, the prospective 
bronchial system and distally, the prospective respiratory system. The bronchial system is 
lined by high columnar epithelial cells, whereas the respiratory system is initially lined by 
low columnar or cuboid immature type II cells and later by cuboid type II cells and 
squamous type I cells (Ten Have-Opbroek 1981). Finally, respiratory tubules, terminal 
sacs, and alveoli, together with blood capillaries, nervous, and connective tissue will form 
the adult respiratory system. 
Figure 5 Fetal rat lung (day 17) incubated with anti-collagen III antiserum and stained with a 
peroxidase-labelled secondary antibody and DAB. A linear staining pattern is present around the 
acinar tubules (small arrows), around bronchi (arrow) and vessels, and in septa (arrowheads). 
200x. 
Figure 6 Fetal Tat lung (day 17) incubated with anti-collagen IV antiserum and stained according 
to the PAP-technique. A linear staining pattern is present around acinar tubules and bronchi 
(arrows), and around blood vessels (arrowheads). Note that staining is absent around tubules 
growing towards the pleura (small arrows). 200x. 
Figure 7 Fetal rat lung (day 15) incubated with anti:fibronectin antiserum and stained with a 
peroxidase-labelled secondary antibody and DAB. Staining is present around bronchial and acinar 
tubules. Underneath high columnar epithelial cells (arrows) staining is much more intense than 
under low columnar to high cuboid cells (small arrows). Along distalmost acinar tubules no 
staining is present at all (arrowhead). 200x. 
Figure 8 Fetal rat lung (day 17) incubated with anti-laminin antiserum and stained according to 
the PAP-technique. A linear staining is present underneath the epithelial cells of all tubules 
(arrows). Cuboid alveolar epithelial cells show a cytoplasmic staining for laminin (arrowheads), 
while columnar bronchial epithelial cells remain negative. 22Ox. 
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Nitrofen exposure results in pulmonary hypoplasia (Tenbrinck et al. 1990; Brandsma et a1. 
1994b). As mentioned before, it is unknown whether this hypoplasia results from a 
decreased proliferation or differentiation. 
Proliferation 
Our findings on day 13, i.e. a decreased length of the lung primordium after Nitrofen-
exposure (Brandsma et a1. 1994a), and the results from other authors (Iritani 1984; Nakao 
et a1. 1990; Ueki et al 1990) who also describe such an early effect of Nitrofen on lung 
growth, are not readily explained by Manson's theory (1986). This author suggests a 
transient stimulation of lung differentiation by Nitrofen at the expense of lung growth. In 
other words, a stimulation of differentiation precedes, and eventually results in a 
decreased lung growth. Based on this theory, one would expect to find smaller lungs later 
in gestation, and not as early as day 13. However, an early effect is of course not 
excluded by Manson's theory. On the other hand, our before-mentioned findings do 
suggest a decrease in proliferation rate of the early fetal pulmonary epithelium in the 
Nitrofen-exposed group which may result in a retarded differentiation. Using antibodies 
against PCNA however, there is no difference in proliferation rate demonstrable between 
the two experimental groups. This apparent contradiction can be explained in several 
ways. 
Possibly, the onset of the outgrowth of the lung bud starts later, so that the absolute 
number of proliferating cells at any given moment is smaller than in the control group. 
Nakao et a!. (1990) describe a 6-12 hours delay in lung bud formation in both rat and 
mice after Nitrofen-exposure compared to control animals. In the other above-mentioned 
publications (Iritani 1984; Ueki et a1. 1990), as in our own work, a decreased lung length 
or lung weight at an early embryonic age is described, but the onset of lung bud formation 
is not included in the studies. To investigate this, smaller time intervals between the 
sacrifices of the experimental animals as well as counting of the total amount of 
proliferating cells at each time point are necessary. 
Another option is that a decreased growth in length of the lung primordium goes along 
with premature branching, which would not result in a decreased proliferation rate either. 
A study of the three-dimensional growth of the primordial system could give an answer to 
this question. 
Another explanation for the PCNA staining results is that the method is not suitable for 
this purpose. The 36 kDa proliferation cell nuclear antigen (PCNA, cyclin) is an 
intranuclear polypeptide which begins to accumulate during the Gl phase of the cell cycle, 
is most abundant during the S phase of the cell cycle, and declines during the G2/M phase 
(Hall and Woods 1990). Therefore, PCNA is a very sensitive detection method for 
ongoing or recent cell replication, and maybe not so useful in embryonic tissue, in which 
proliferation rates are expected to be very high. Bromodeoxyuridine (BRDU) 
incorporation occurs only during S phase, resulting in a lower percentage of positive, 
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proliferating cells (Zeymer et a1. 1992). Use of this method might reveal a difference in 
proliferation rate between control lungs and Nitrofen-exposed lungs after all. This is 
currently under study in our laboratory. 
Differentiation 
Epithelial branching is one of the major events in lung morphogenesis. The branching 
proces depends on the interaction of the epithelium with the mesenchyme; the amount of 
mesenchyme as well as its source (lung versus non-lung, terminal versus proximal) is 
shown to be of importance in in vitro studies (Gross 1990; Hilfer et al. 1985; Masters 
1976; Taderera 1967). It seems likely that mesenchyme supports the morphogenesis and 
differentiation of the respiratory epithelium in part through the type of matrix that it 
synthesizes and deposits (Brody 1985; Edelson et a1. 1989; Lwebuga-Mukasa 1991; 
McGowan 1992; Rannels and Rannels 1989a,b; Shannon et a1. 1987; Warburton et a1. 
1993). Among the components of the extracellular matrix that have been indicated as 
being necessary for branching are the collagens (Arden et a1. 1993; Chen and Little 1987; 
Hashimoto and Hoshino 1988; Heine et al. 1990; Nerlich et a1. 1985), fibronectin (Chen 
et a1. 1986; Roman and McDonald 1992; Rosenkrans et a1. 1983; Snyder et al. 1987), and 
laminin (Chen et a1. 1986; Schuger et a1. 1990, 1992). The present study describes the in 
vivo expression of these extracellular matrix factors in normal and in Nitrofen-exposed, 
and thus hypoplastic fetal rat lungs. The expression patterns found, correspond with those 
described by other authors for the collagens (Arden et al. 1993; Brody 1985; Chen and 
Little 1987; Heine et al. 1990; Nerlich et a1. 1985), and fibronectin (Chen et a1. 1986; 
Heine et al. 1990; Roman and McDonald 1992). For laminin we find a different staining 
pattern than most other authors: in addition to basal lamina staining, we also find staining 
of primordial epithelial cells and cuboid alveolar type II cells. Schuger et al. (1992) 
describe that both lung epithelium and mesenchyme produce complete laminin molecules, 
shown by immunohistochemistry and in situ hybridization studies. Our results do not show 
any differences in expression pattern of the before-mentioned differentiation markers 
between control and Nitrofen-exposed rats. Neither Manson's theory of a transient 
stimulation of differentiation by Nitrofen, nor our own theory of a retarded differentiation 
after Nitrofen exposure is supported by this outcome. It could be that, though the pattern 
of expression is the same, the quantity of expressed matrix factors differs between the two 
groups. However, such conclusions can not be drawn from our immunohistochemical 
results; for this, biochemical analysis would be required. 
It is possible that a difference between control and Nitrofen-exposed lungs will be found 
by staining for other factors that are known to regulate morphogenesis and differentiation 
of the lung, such as the group of cell adhesion molecules (e.g. integrins, cadherins) or 
growth factors (e.g. PDGF, TGFB). In a previous study we have shown that Nitrofen 
reduces the binding of triiodothyronine (T3) to its receptor (Brandsma et a1. 1994c). As 
thyroid hormones are known to have a trophic effect on lung development and 
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differentiation of epithelial cells, it is of interest to study the expression of the nuclear T3-
receptor in early fetal rat lungs exposed to Nitrofen (currently under investigation in our 
laboratory). 
In conclusion, our results from the present study, in which we use a number of 
proliferation and differentiation markers besides measurements of length in normal and in 
Nitrofen-exposed lungs, unfortunately do not fully answer the question, whether 
pulmonary hypoplasia results from a decreased proliferation or differentiation. However, 
studies by us and other investigators suggest that Nitrofen may possibly cause a retarded 
onset of lung bud development or an altered growth pattern of the lung such as premature 
branching, both of which may affect the growth in length of the organ. 
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INIllBITION OF T)-RECEPTOR BINDING BY NITROFEN 
6.1 Summary 
Lung development is controlled by various hormones, including thyroid hormone. The 
herbicide 2,4-dichlorophenyl-p-nitrophenyl ether (Nitrofen) induces lung hypoplasia in 
fetal rats, when administered to the mother during gestation. Nitrofen might be teratogenic 
by an anti-thyroid activity. The present study shows that Nitrofen decreases the binding of 
TJ to the 0'1 and fil form of the thyroid hormone receptor in a non-competitive way. 
Consequently, rat lung hypoplasia might result from the decreased binding of T, to its 
receptor, via exposure to Nitrafen during fetal development. 
6.2 Introduction 
Lung development is controlled by various hormones, including glucocorticoids and 
thyroid hormone. Thyroid hormone is known to have a trophic effect on lung development 
(Ballard 1983; Gross 1990; Hitchcock 1979). The herbicide 2,4-dichlorophenyl-p-
nitrophenyl ether (Nitrofen) is a potent teratogen in rodents. Administration of 100 mg 
Nitrofen to pregnant rats on day 10 of gestation results in pulmonary hypoplasia and a 
closing defect of the diaphragm known as congenital diaphragmatic hernia in the offspring 
(Kluth 1990; Tenbrinck 1990). However, exposure of pregnant rats to Nitrofen on other 
gestational days leads to hydronephrosis, cardiac malformations, and eye anomalies in the 
neonates (Burke Hurt et a!. 1983; Costlow and Manson 1981; Gray et a!. 1982; Lau et al. 
1986; Ostby et a!. 1985). The similarity in stereochemical structure between Nitrofen and 
thyroid hormones suggested an alteration of thyroid function by Nitrofen (Gray and 
Kavlock 1983). Exposure of euthyroid pregnant rats to Nitrofen indeed resulted in an 
initial depression of serum thyroxine (T4) levels followed by an increase exceeding normal 
serum T4 levels in the mother rats at term; serum triiodothyronine (T3) was normal or 
slightly elevated (Manson 1986; Manson et a!. 1984). In the near term fetus a decreased 
T4 level and normal T, and thyroid stimulating hormone levels were found (Manson 1986; 
Manson et a!. 1984). After coadministration of T, and Nitrofen to pregnant rats a dramatic 
reduction (70%) in the frequency of malformations in the offspring occurred (Manson et 
a!. 1984). Nitrofen competed with ['25I1T4 for binding to rat thyroid binding globulin in 
vitro (Manson 1986), From these studies it is likely that Nitrafen exerts its teratogenic 
effects via alterations in the thyroid hormone metabolism. We investigated the effect of 
T,-RECEPTOR AND NITROFEN 93 
Nitrofen on the binding of thyroid hormone to the "I and BI form of the thyroid hormone 
receptor obtained from bacteria by recombinant DNA techniques. Our resuIts have led to 
the hypothesis that Nitrofen directly interacts with the nuclear thyroid hormone receptor. 
In the embryo this may lead to abnormal organogenesis. Some of the observations have 
been published in an abstract (Brandsma et ai. 1993a). 
6.3 Materials and Methods 
Chemicals 
Triiodothyronine (T,) was obtained from Henning GmbH (Berlin, FRG) and [125I]T, 
(specific activity 2200 Ci/mmol) was purchased from New England Nuclear (Boston, 
USA). 2,4-Dichlorophenyl-p-nitrophenyl ether (Nitrofen) was a generous gift from Rohm 
and Haas Company (Springhouse, Philadelphia). 
Receptor proteins 
The pEX plasmid (Stanley and Luzio 1984) was used as a bacterial expression vector in 
the E.coli pop 2136 strain (Vidal-Ingigliardi and Raibaud 1985) containing the cIts857 
repressor. The c-ERB A coding sequences of chicken" type (full length, encoding amino-
acids 1-408) (Sap et ai. 1986), or rat B type (encoding amino acids 31-456) (Murray et ai. 
1988) were introduced into this vector. Both sequences contain the hormone- and DNA 
binding domain. In addition, the affinity constants (K,) of the receptor proteins for T3 
(K.~1.1 1010 for "I; K"~5.2 109 for BI ) are in the same range as we found for whole 
nuclei (K.~2.2 109) and as described in the literature (Van der Klis et aI. 1991, Wiersinga 
1985). C-ERB A fusion proteins were isolated as described by Stanley and Luzio (1984) 
and stored in solution A (20 mM Tris-HCI, 0.25 M sucrose, 1 mM EDTA, 50 mM NaCl, 
5% (v/v) glycerol, pH 7.6) in liquid N,. Polyacrylamide-gelelectroforesis of the proteins 
after incubation with Bromo-acetyl-[!25I1T3 showed that approximately 10 to 15% of total 
protein expressed by the bacterial system is the "lor BI receptor (Van der Klis et ai. 
1991). The molecular weight of the receptor proteins was calculated as 45 to 50 kD. 
Autoradiography of the gel demonstrated that only proteins with a Mw corresponding to 
the receptor bind T, (Van der Klis et ai. 1991). 
Binding studies 
Prior to each incubation the fusion protein suspension was thawed, solubilized by 
sonification (10 seconds, 6 microns), and the non-soluble fraction was pelleted by 
centrifugation (IO,OOOxg, 5 minutes, 4°C). 401'1 c-ERB A protein suspension was added 
to solution A with [125J]T3 and 5 mM dithiothreitol in the absence or presence of various 
concentrations of nonradioactive T3 andlor Nitrafen dissolved in 7.5% ethanol. 500 1'1 of 
this mixture was incubated for 2 hours at 22°C in a shaking water bath. Incubations were 
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stopped by chilling the samples in ice-cold water. Separation of bound and unbound 
hormone was performed at 4°C by elution with solution A using Sephadex G-25 Medium 
(Pharmacia, Uppsula, Sweden) columns in a Pasteur pipette (bed volume approximately 
2.5 ml) (Hartong and Wiersinga 1985). Fractions of 0.8 ml were collected from the 
columns and the 1251 radioactivity measured. The first four fractions were taken to 
represent the hormonal fraction bound to the c-ERB A proteins (Hartong and Wiersinga 
1985). Specific binding was determined by subtracting the non-specific binding, i.e. 
[ 125IlT, bound to c-ERB A protein in the presence of an excess (l0·7M) nonradioactive T,. 
6.4 Results 
Mean specific binding of e"IlT, to the expressed ", chicken and B, rat receptor 
proteins under the conditions used was 44.9% and 31.5% respectively; mean non-specific 
binding was 4.3% and 4.6%. Expression products of the vector pEX without c-ERB A 
coding sequences did not bind ['25IlT, specifically. A linear relationship existed between 
specific binding and protein concentration for both the ", and B, type of thyroid hormone 
receptor up to 45 1'1 protein suspension. 
Incubation of the receptor proteins with [125IlT, in the presence of the solvent ethanol 
(7.5%) reduced the mean specific binding to 40.0% and 19.8% for ", and B, respectively. 
Incubation in the presence of ImM Nitrofen further reduced the mean specific binding to 
30.5% and 14.8%. Reduction of T,-binding to the ", receptor in the presence of 100 I'M 
Nitrofen is shown in figure 1. 
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Figure 1 Binding of P"I]T, to 
the (Xl receptor. The ct.] receptor 
was added to solution A with 
t 25I}Tj in the absence or presence 
oj Nitro/en or an excess of 
nonradioactive Tp and incubated 
at 22°C, At various time points a 
sample was taken, bound F25JJTJ 
was separated and counted. Note 
that both Nitro/en and an excess 
oj nonradioactive T; reduce the 
binding of [WIJT] to the receptor. 
Scatchard analysis showed that ethanol decreased the affinity (slope of the curve) of T3 
for the receptor, whereas Nitrofen decreased the maximal binding capacity (MBC; 
intercept on the x-axis) of the receptor for T3 in both the ", (Fig. 2) and B, (not shown) 
receptor type. The affinity constant K. of T, for the ", T,-receptor in the presence of 
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Figure 2 Scatchard plots ~f the binding of T, to 
the ct.} receptor. The ct.} receptor was added to 
solution A with f 25I}TJ in the absence or presence 
of Nitrofen or 7.5% ethanol, and in the presence 
of various concentrations nonradioactive TJ• After 
2 hours incubation at 22 0 C the amount of bound 
TJ was counted and Scatchard plots were made: 
without any additions (Ko 1.58·lO"L1M; MBC 
7.11·]()nM), in the presence of 7.5% ethanol 
(Ko 1.0l·lO"L1M; MBC 6.8·1(}IIM), and in the 
presence of lmM Nitrofen dissolved into 7.5% 
ethanol (Ko O.94·10"LlM; MBC 5.16·]()IIM). It 
is shown that (~thanol decreases the affinity 
constant (KJ, whereas Nitrofen decreases the 
maximal binding capacity (MBC). 
Figure 3 Scatchard plots of the binding ~f T, to 
the a} receptor. The ct.} receptor was added to 
solution A with f 25I}TJ ill the presence of various 
concentrations of Nitrofen and nonradioactive TJ • 
After 2 hours incubation at 22°C the amount of 
bound T] was counted and Scatchard plots were 
made. Note the dose dependent decrease of 
maximal binding capacity by Nitrofen. 
Nitrafen and the solvent ethanol was 0.6 1010 ± 0.18 1010 LIM. The MBC in the presence 
of ethanol only was 7.6 10.11 ± 0.84 10-11 M, whereas the MBC in the presence of I mM 
Nitrafen and ethanol was 4.96 10-11 ± 0.99 10.11 M (p=0.04). The effect of Nitrofen was 
dose-dependent (Fig. 3). 
Lineweaver-Burk analysis of the experiments depicted in figure 1 and 2 revealed a non-
competitive inhibition by Nitrofen, as shown by intersection of the lines on the base line 
(Figs. 4, 5). In accordance with the Scatchard analysis, the solvent ethanol appeared to be 
a competitive inhibitor (Fig. 4). The inhibition constant K, for Nitrafen could be 
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* Figure 4 Lineweaver-Burk plots of the effect oj 
7.5% ethanol and lmM Nitro/en dissolved into 
7.5% ethanol on the binding of T3 to the (Xl 
receptor type. The a] receptor was added to 
solution A with f25]JTJ in the absence or presence 
of Nitro/en or 7.5% ethanol, and in the presence 
of various concentrations nonradioactive T3• After 
2 hours incubation at 22°C the amount of bound 
TJ was counted and Lineweaver-Burk plots were 
made. The 'ethanol line' and the 'Nitro/en line' 
intersect on the base line, revealing a non-
competitive inhibition mechanism, while the 'no 
addition and ethanol lines' intersect at the y-axis, 
showing that ethanol is a competitive inhibitor. 
Figure 5 Lineweaver-Burk plots oj the effect oj 
Nitrojen on the binding oj T3 to the Q'l receptor 
type. The Q'] receptor was added to solution A 
with FZ5I}T3 in the presence of Various 
concentrations oj Nitrojen and nonradioactive T3 . 
After 2 hours incubation at 22°C the amount oj 
bound T3 was counted and Lineweaver-Burk plots 
were made. Note the intersection oj all three 
lines on the baseline, revealing a non-competitive 
inhibition mechanism. 
determined graphically by plotting IIBound T, versus the concentration of Nitrofen. For 
non-competitive inhibitors the intercept of the x-axis represents the Kj-value. This was 
found to be 1.2 1O-'M for the "'I protein (Fig. 6) and 1O-3M for the BI protein (not shown). 
Delayed addition of Nitrofen to the incubation mixture resulted in a decrease of [125I]T3 
binding in a similar way as delayed addition of non-radioactive T3; the two effects seemed 
to be additive (Fig. 7). 
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6.5 Discussion 
Figure 6 K, plot; graphical 
determination oj the inhibitor 
constant K; of Nitrofen for the 
binding oj TJ to the ct.] receptor type. 
Figure 7 Binding of [w liT, to the 
ct.1 receptor. The ct.] receptor was 
added to solution A with t 25I]I'; in 
the absence or presence of an excess 
oj nonradioactive TJ> and incubated 
at 2rc. After 2 hours 7.5% 
ethanol, Nitro/en, nonradioactive TJ> 
or a combination of NitroJen and TJ 
was added to the incubation mixture. 
At various time points a sample was 
taken, and bound [WIJT, was 
separated and counted. Dissociation 
of bound TJ occurred by the addition 
of Nitrofen, nonradioactive Tp or a 
combination 0/ the two. 
Our results demonstrate that Nitrofen inhibits the binding of ['25I1T3 to the Oi, and fi, 
form of the recombinant thyroid hormone receptor. The inhibition is dose dependent and 
non-competitive in character. Rather high concentrations of Nitrofen are necessary to 
achieve the inhibitory effect. Nitrofen is known to be a very lipophilic substance; 
concentrations of Nitrofen in fat can easily be 100 times higher than in blood (Brown and 
Manson 1986; Costlow and Manson 1983). In accordance with the accumulation in fat, we 
think that Nitrofen can also concentrate in lipoid membranes, and thus locally reach very 
high concentrations. If Nitrofen binds to the same binding site as T3 , which has been 
suggested by Manson (1986) based on the resemblance in stereochemical configuration, 
the inhibition mechanism would be competitive in character. The observed non-
competitive inhibition indicates that Nitrofen binds to a different site on the receptor than 
T, itself. 
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In addition to the inhibitory effect of Nitrofen on the binding of T3 to the T3-receptor, 
maternal and fetal serum T, levels decrease after Nitrofen-exposure. Also, lungs become 
hypoplastic after Nitrofen-exposure (Tenbrinck et a!. 1990), and a retarded development 
of the future air spaces (Brandsma et a!. 1992), of type I (Brandsma et al. 1992) and of 
type II alveolar epithelial cells (Brandsma et al. 1993b) occurs. All these findings are not 
in agreement with a thyreomimetic effect, as suggested by Manson (1986). This author 
states that Nitrofen exposure results in a thyreomimetic challenge to the conceptus, 
because slight increases in phospholipid levels were measured and a dose-related increase 
in malic enzyme activity was found late in gestation. However, from our findings we must 
conclude that Nitrofen-exposure most likely results in a thyreostatic challenge to the 
conceptus. This effect can be achieved by a non-competitive inhibition of the binding of 
T3 to the nuclear T3-receptor by Nitrofen. 
The expression of the nuclear T,-receptor in fetal rat lungs and the distribution of Nitrofen 
in the fetus are currently under investigation in in vivo experiments. Nitrafen might 
possibly interfere also at other levels with thyroid hormone metabolism. 
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CONGENITAL DIAPHRAGMATIC HERNIA: 
NEW MODELS, NEW IDEAS. 
7.1 Clinical background 
Congenital diaphragmatic hernia (CDH) is an anomaly with unknown etiology and an 
incidence of 1:3000 liveborns. Despite progress and tremendous effort in neonatal and 
surgical intensive care the mortality rate has not changed in the last 30 years and remains 
30-50%. The outcome of these patients depends mainly on the gravity of pulmonary 
hypoplasia or on the combination of pulmonary hypoplasia with persistent pulmonary 
hypertension (Molenaar et a!. 1991; Wenstrom et al. 1991). 
Structural changes have been demonstrated in the pulmonary parenchyma of patients such 
as: delayed maturation of alveolar structures (Nakamura et a!. 1991) and a decreased 
number of bronchial branches (Kitagawa et a!. 1971). Not only the lung parenchyma but 
also the pulmonary vascular system shows abnormalities in CDH patients. A decrease in 
total size of the pulmonary vascular bed, increased thickness of the pulmonary arterial 
smooth muscle coat, and a decreased number of vessels per unit of lung is found (Geggel 
et a!. 1985; Shochat 1987). In the last 5 years, different clinical approaches have been 
used in an attempt to influence the overall mortality in CDH patients. These include 
delayed surgery, alternative ways of artificial ventilation, extracorporeal membrane 
oxygenation (ECMO), and exogenous surfactant application in selected patients. Even 
intrauterine repair and postnatal lung transplantation have been advocated in this respect. 
7.2 Clinical perspectives and research questions 
In neonatology, prematurely born infants with respiratory distress syndrome are treated 
by modulating lung differentiation by application of corticosteroids starting before birth to 
enhance the type II alveolar epithelial cells to increase surfactant production. In addition to 
glucocorticoids, thyroid hormone is another known trophic factor modulating lung growth 
(Hitchcock 1979). Recently thyrotropin-releasing hormone has been suggested to stimulate 
pulmonary differentiation (Devaskar et a!. 1991; De Zegher et al. 1992). Therefore, fetal 
hormonal modulation improving lung growth capacity might be preferable to fetal surgical 
closure of the diaphragmatic defect. However, when the liver, bowel loops, and 
developing lung parenchyma compete for space in the fetus, it is doubtful whether growth 
factors should be given to the pregnant mother to stimulate lung growth in prenatally 
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diagnosed CDH patients. To combine fetal surgery with prenatal enhancement of lung 
growth by growth factors, either by systemic or local application, is one of the options to 
be investigated in the near future. 
As soon as the newborn with CDH is artificially ventilated, oxygen free radicals will have 
a major effect on lung parenchyma. Two therapeutic options are available, being primary 
ECMO treatment (Cornish et a1. 1987; O'Rourke et al 1991; Wilson et a1. 1991) or 
application of antioxidant enzymes (Tanswell and Freeman 1987). Primary ECMO 
treatment of all patients with CDH to prevent oxygen-induced lung damage will however 
result in overtreatment of at least 50 % of CDH patients who would survive without 
BeMO treatment and escape its intrinsic hazards (intraventricular haemorrhage, carotic 
ligation). Intratracheal instillation of antioxidant enzymes like polyethyleenglycol bound 
superoxide dis mutase or catalase might be considered as a less aggressive way of 
treatment with comparable results. 
Experimental studies in pigs are now performed to evaluate the possibility of neonatal 
lung transplantation to overcome the problem of pulmonary hypoplasia. The actual size of 
the transplanted lung, the best lobe to choose and whether it should be a living related 
transplantation (parent-child) are currently under study (Shochat, personal 
communications). In this approach ECMO can be considered as a bridge to 
transplantation; case reports have documented the use of ECMO for this purpose. 
7.3 Experimental induction of CDH 
In the classical view of treating patients with CDH the abdominal viscera were removed 
out of the thorax as soon as possible after birth to provide space for the lungs to expand. 
According to this concept the group of Harrison performed a number of classical studies 
with pregnant sheep, inducing CDH by means of intrauterine operative techniques in the 
fetuses (Harrison et aI. 1980; 1981). Their aim was to generate an animal model 
representing CDH appropriate for intrauterine repair enabling enhancement of lung 
growth. Several disadvantages accompany this sheep model such as surgical interference 
in a relatively late stage of lung development, high costs for small numbers, while 
information concerning the pathogenesis of CDH can not be obtained. More recently Glick 
and coworkers used this animal model to study the functional characteristics of the 
hypoplastic lung in relation to surfactant production (Glick et a1. 1992). 
A different approach to study the pathogenesis of CDH with respect to morphology and 
functional activity of the lung is used by different groups including our own group 
(Alfonso et aI. 1993; Iritani 1984; Kluth et a1. 1990; Suen et aI. 1993; Ueki et aI. 1990). 
This approach is based on the use of a teratogenic agent known to interfere with lung and 
diaphragm development. 
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7.4 Toxicological background 
2,4-Dichlorophenyl-p-nitrophenyl ether (Nitrofen) has been known as a teratogen with 
effects on the diaphragm and lung both in rats and mice (Costlow and Manson 1981; 
Iritani 1984; Kimbrough et al. 1974; Lau et aI. 1988; Stone and Manson 1981; Veki et al. 
1990). 
Experiments with radioactively labelled Nitrofen have shown that only 1-5% of Nitrofen 
passes the placenta; Nitrofen radioactivity was detected in the embryonic tissue 
compartment from 3 hours after application to the mother reaching peak concentrations at 
72 hours (Manson 1986). Nitrofen is degraded to hydroxylation, nitroreduction, and 
acetylation products, which do not show any teratogenic effect by itself (Manson 1986). In 
the embryo only the native compound can be detected (Manson 1986). In other words the 
teratogenic effect is not mediated via generation of mutagenic intermediates through 
nitroreduction of the parent compound. 
Experimental data have shown that the effect of Nitrofen is highly dependent on the 
gestational age of the fetus (Costlow and Manson 1981). The most susceptible period with 
respect to interference with lung development is from day 9-12 in the rat, which is the 
actual stage of early lung development. Veki has described a decreased weight gain of the 
lung primordium as early as 3 days after experimental application of Nitrofen on day 11 
(Veki et aI. 1990); our own group found a significant reduction in growth of the lung 
primordium also three days after Nitrofen-exposure (Piersma et al. 1993). 
The stereochemical configuration of Nitrofen resembles that of triiodothyronine (T,) and 
thyroxine (T,) to a great extent while application of Nitrofen to pregnant mother rats 
resulted in a decrease in thyrotropin-stimulating hormone and T" without major alterations 
of T, in the mothers, as well as a decrease of T, in the fetuses (Gray and Kavlock 1983; 
Manson et aI. 1984). Combined application of Nitrofen and T, to rats that had been 
thyroidectomised resulted in 70% reduction of the frequency of congenital anomalies in 
the offspring (Manson et aI. 1984). 
In vitro studies performed by our research group have shown that incubation of nuclear T3 
receptor proteins with T3 in the presence of Nitrofen decreased the specific binding of T, 
to the (Xl and 81 form of the thyroid hormone receptor (Brandsma et al. 1993b). The effect 
was dose-dependent (10 I'M - 1000 I'M). Scatchard analysis revealed that Nitrofen 
decreased the maximal binding capacity of the receptor while Lineweaver-Burk analysis 
demonstrated the inhibition to be non-competitive in character. We concluded that 
Nitrofen inhibits the binding of T, to the (Xl and 81 form of the nuclear T,-receptor in a 
non-competitive way by decreasing the maximal binding capacity. 
Consequently, lung hypoplasia might result from a decreased binding of T, to its receptor. 
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7,5 Experimental approach 
General methods 
Adult Sprague-Dawley rats were mated overnight at our laboratory animal center; the next 
day was designated day 1. On day 10 of pregnancy, a single dose of 100 mg Nitrofen 
dissolved into olive oil was given to the mother rats through a stomach tube, resulting in 
large left-sided defects in about 80-90% of the offspring. Previously, we have been using 
115 mg/kg body weight at day 11.5 of gestation, which resulted in smaller right-sided 
defects in about 60% of the offspring. Pregnancy was continued without specific 
measurements, food and water were supplied ad libitum. Spontaneous delivery was 
awaited (term=day 22-23), or Caesarean section was performed. After "birth" body 
weights were determined; at autopsy the presence of a diaphragmatic defect, the position 
(right- or left-sided), and size of the defect, as well as the nature of the intrathoracic 
contents (liver, bowel) were evaluated. 
Hypoplasia of the lungs 
To evaluate the presence of pulmonary hypoplasia after exposure to Nitrofen, newborn 
rats were weighed and killed by intraperitoneal injection of an overdose of pentobarbital 
(Nembutal; Sanofi, Tinderberg, The Netherlands). The lungs were dissected out and left 
and right wet lung weights were determined using a Mettler balance enabling calculation 
of the lung weight/body weight index. To prevent collapse of the lungs, tracheal 
cannulation and fixation with Davidson solution (40 vol% ethanol 100%; 5 vol% acetic 
acid 96%; 10 vol% formaldehyde 37%; 45 vol% saline; pH 7.3) under constant pressure 
(20 em H20) was performed according to Burri (Burri et a!. 1974) for at least 24 hours. 
The lungs were embedded in paraffin; six micron slides were made and stained with 
hematoxylin and eosin. Morphometric analysis to determine radial saccular count was 
performed on at least 3 different slides using a magnification of 250 x. At least 10 radial 
saccular counts per slide were evaluated. Radial saccular counts were plotted against lung 
weight/body weight index according to Askenazi (Askenzi and Perlman 1979). 
The mean body weights and lung weights (including standard deviations) as well as the 
lung weight/body weight ratio and the right lung/left lung weight ratio have been 
published in detail before (Tenbrinck et a!. 1990). At term the mean body weight in the 
Nitrofen-exposed group with CDH (4.8 g ± 0.3) differed significantly from that in the 
control group (5.7 g ± 0.3). The same holds true for total lung weight (Nitrofen-exposed 
group with CDH: 91.9 mg ± 24, control group: 151.7 mg ± 17.3) and for radial 
saccular counts. In all cases both left and right lungs were significantly smaller in the 
Nitrofen-exposed group with CDH than in the control group. Plotting of the radial 
saccular counts against the lung weight/body weight indexes indicated severe hypoplasia of 
the lung in cases with CDH. Intermediate values were found in the Nitrofen-exposed 
group without CDH. 
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Architecture of the lung and alveolar cell composition 
To compare the architecture and alveolar epithelial cell composition of the pulmonary 
acinus in hypoplastic and normal fetal lungs, sections (5 I'm) from lungs of control and 
Nitrofen-exposed fetal rats aged 18-22 days were stained with hematoxylin and eosin. To 
identify developing alveolar epithelial cells, fresh-frozen sections (6 I'm) were incubated 
with anti-Surfactant Protein A (SP-A; rabbit anti-mouse) or preimmunization serum 
(indirect immunofluorescence). Criteria to identify immature and mature type II alveolar 
epithelial cells are: approximately cuboid shape, large and roundish nucleus and 
cytoplasmic fluorescent staining for SP-A (Ten Have-Opbroek 1981; 1991). Developing 
type I cells (deriving from type II cells) are low cuboid to squamous, and finally lack sp-
A (Ten Have-Opbroek 1981; 1991). 
On days 18 and 19, control and Nitrofen-exposed lungs were in the pseudoglandular stage 
of lung development and looked similar. The prospective pulmonary acinus consisted of 
tubules with small round lumens, lined by approximately cuboid, fluorescent epithelial 
cells with large and roundish nuclei (acinar tubules) (Ten Have-Opbroek 1991). On day 20 
(canalicular stage), some tubules were slightly dilated and lined by cuboid and thinner 
fluorescent cells; these tubules were less numerous in exposed lungs. On days 21 and 22, 
exposed and control lungs were in the saccular stage of lung development. In exposed 
lungs from fetuses with and without CDH the entire saccular lining consisted of cuboid 
and low cuboid to thin fluorescent cells, whereas in control lungs fluorescent (low) cuboid 
cells were interspersed with a few (day 21) or many (day 22) dark zones. In the exposed 
lungs from fetuses with CDH, the lumens of air spaces were frequently slit-like, septa 
were thicker I and acinar tubules were more abundant. These phenomena gave the exposed 
lungs a primitive, compact aspect. 
In conclusion, Nitrofen-exposed, and thus hypoplastic, fetal rat lungs are retarded with 
respect to the differentiation of cuboid type II cells into squamous type I cells whether or 
not CDH is present and with respect to the development of the future air spaces between 
days 20 and 22 if CDH is present (Brandsma et al. 1992). 
Ultrastructural features of alveolar epithelial cells 
To investigate the ultrastructural morphology of type I and type II cells, our light 
microscopical studies were expanded with electron microscopy of lung tissue from control 
and Nitrofen-exposed fetal rats aged 19-22 days. Semithin (I I'm) Epon sections were 
stained with toluidine blue, and ultrathin sections (ca. 80 nm) were stained with uranyl 
acetate 7 % and lead citrate. Electron microscopical features were described and 
interpreted according to Ten Have-Opbroek (Ten Have-Opbroek et al. 1988; 1990). 
On day 19 both control and Nitrofen-exposed lungs contained only cuboid alveolar 
epithelial cells. From day 20 we found cuboid, low cuboid and thinner epithelial cells. 
The (low) cuboid cells contained large glycogen fields, some precursory stages of multi-
lamellar bodies (MLBs), and just a few mature MLBs on days 19 and 20; smaller 
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glycogen fields, more precursory stages and more mature MLBs on day 21; and little or 
no glycogen but many precursory stages and mature MLBs on day 22. The thinner cells 
contained little or no glycogen and a few precursory stages of MLBs on days 20 through 
22; very thin cells on day 22 contained neither glycogen nor any precursory or mature 
stages of MLBs. MLBs and tubular myelin were seen in the lumens of future air spaces 
from day 20 onward. 
Nitrofen-exposed lungs differed from control lungs in that inclusion bodies were less 
abundant in (low) cuboid alveolar cells on days 19 and 20, and more glycogen was seen 
on day 22. In other words, type II cells were less mature than in control lungs (Brandsma 
et al. 1993a). 
The pulmonary vasculature 
Microscopy: For the evaluation of the pulmonary arterial vessels a heated barium gelatine 
solution was perfused into the pulmonary arterial trunk under constant pressure. The 
perfusion was stopped when this white solution reached the visceral pleura in all segments 
leading to 'snow flocks'. Subsequently, tracheal cannulation was performed as described 
above for fixation of the lung. With the aid of an ocular eye piece micrometer and 
constant magnification (x250) the pulmonary vessels were evaluated with respect to the 
external diameter, medial wall thickness and muscularity of the vessel wall. 
Both at the level of conducting airways as well as at the level of the terminal bronchioles 
differences were found consisting of a peripheral extension of the muscular arteries in the 
hypoplastic lung together with an increase in medial wall thickness (Tenbrinck et a1. 
1992). 
Eicosanoids: The eicosanoid content in bronchoalveolar lavage (BAL) fluid from Nitrofen-
exposed neonatal rats with CDH and control rats was determined. In one group, BAL was 
performed after Casarean section on day 22 before any breathing movement could take 
place. In another group, BAL was performed directly after spontaneous birth. Contents of 
6-keto-prostaglandin-F1• (6-k-PGFIJ and thromboxane B, (TxB,) were measured in BAL 
by radioimmuno assay. 
In control rats, the mean concentration of 6-k-PGF1• (with a known vasodilatory effect) in 
BAL was significantly higher after spontaneous birth than after Caesarean section, 
whereas in rats with CDH this increase could not be demonstrated. The mean 
concentration of TxB, (a vasoconstrictive agent) increased significantly during birth in the 
Nitrofen-exposed group with CDH, but not in de control group; despite the increase 
during birth, TxB, concentrations in the CDH group were significantly lower than those in 
the control group. These phenomena might play a role in the occurrence of pulmonary 
hypertension in CDH, although we realize that the eicosanoid content of BAL does not 
necessarily reflect that of the pulmonary vasculature (IJsselstijn et al. 1994). 
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Pulmonary neuroendocrine cells (PNEC): Amine and peptide producing PNEC, widely 
distributed throughout airway mucosa, are thought to play an important role in both 
pulmonary development and regulation of pulmonary vascular tone. Furthermore, recent 
studies show modulation during chronic hypoxia of calcitonin gene-related peptide 
(CGRP), a pulmonary vasodilator produced by PNEC (SpringaU and Polak 1993). 
Morphometric analysis of CGRP immunoreactive PNEC clusters, i.e. neuroepithelial 
bodies (NEB), was performed in sections of lungs from Nitrofen-exposed neonatal rats 
with CDH and control rats. NEB size, and number of NEBs/area of lung were assessed 
using a semiautomatic image analysis system. 
In lungs from Nitrofen-exposed rats with CDH, there is a significant increase in relative 
number of NEBs per surface area of lung parenchyma compared to lungs from control 
rats, whereas the size of NEBs is not significantly affected. Whether this results in altered 
NEB function including imbalance in vasoactive mediators requires further studies. 
Functional studies 
To evaluate the functional significance of the abnormal differentiation of the alveolar 
epithelial cells the following studies were performed. 
Swjactant production: In bronchoalveolar lavage fluid of control and Nitrofen-exposed 
fetuses (day 22) phospholipid fractions and SP-A content were measured. Significantly 
lower total amounts of phospholipids were recovered from Nitrofen-exposed rats by 
bronchoalveolar lavage than from control rats. However, correction for lung weight and 
bronchoalveolar lavage efficiency may reduce the diverging results. The phospholipid pool 
had the same composition, and SP-A per mol phospholipid was the same in 
bronchoalveolar lavage fluid from Nitrofen-exposed rats as in that from control rats 
(Brandsma et al. 1993a). 
SUijactant and artificial ventilation: Preliminary results in newborn infants with CDH 
suggested a positive effect of surfactant administration on oxygenation (Bos et al. 1991). 
To investigate the effect of surfactant on ventilation parameters in our rat model, newborn 
rats were intubated immediately after birth, transferred to a heated multi-chambered body 
plethysmograph, and artificially ventilated. Peak inspiratory pressures (PIP) were initially 
set at 17 cm H,O without any positive end expiratory pressure (PEEP), and a fraction of 
inspired oxygen (FiO,) of 1.0. The pressure was raised in steps of 5 cm H,O from 5 to 30 
cm H20 to obtain pressure/volume diagrams after 0, 1, and 6 hours of artificial ventilation 
(Lachmann et al 1981). These measurements were obtained with and without endotracheal 
instillation of 0.05 ml bovine surfactant (25 mg/ml) in control rats and in Nitrofen-
exposed rats with CDH. 
Significant differences in tidal volume were observed between control rats and Nitrofen-
exposed rats at all time intervals. A positive effect of surfactant application on tidal 
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volume was found in control rats at t= 1 hour. No significant differences were observed 
between the Nitrofen-exposed groups with or without surfactant at t= 1 or t=6 hours 
(Scheffers et a1. 1994). Distribution studies with labelled surfactant will be necessary to 
evaluate the spread of surfactant in both lungs. 
Reaction of the lung on artificial ventilation: Histological examination of neonatal rat 
lungs revealed that after ventilation with PIP of 17 em H20 no aeration of lungs was 
present in control rats and Nitrofen-exposed rats with CDH. The lungs could be aerated 
with PIP of 25 em H20. To evaluate optimal ventilatory strategy, the clinical and 
histological aspects were studied using two different ventilatory settings. Pressure-
controlled artificial ventilation started immediately after birth and was continued for six 
hours. Group I was ventilated with PIP of 25 em H20 all the time; group 2 with PIP of 
25 em H20 for 15 minutes followed by PIP of 17 em H20 for the rest of the time. Other 
settings for both groups were: PEEP 3 em H20, freq. 40/min, and Fi02 1. 
In group 1, 10 out of 11 rats with CDH and 6 out of 10 control rats died due to 
pneumothorax. In group 2, 20 out of 53 rats with CDH died of pneumothorax, whereas 
all 33 control rats survived. Histological investigation revealed a centroacinar pattern of 
lung expansion in lungs from rats with CDH. Aeration was normal in nearly 60% of the 
control rats after 6 hours of artificial ventilation. 
We conclude that in lungs from control rats and from rats with CDH high opening 
pressures are needed, but continuous PIP of 25 em H20 results in high mortality due to 
pneumothorax, especially in rats with CDR. The centroacinar lung expansion and the 
incidence of pneumothorax in CDH rats is similar to the situation seen in premature chil-
dren with respiratory distress syndrome and primary or secondary surfactant deficiency. 
Antioxidant enzyme activity: In another series of experiments the lungs from fetal rats 
(days 19, 20, 21, and 22) were examined for protein and DNA content and activity/mg 
DNA of superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPX). The 
same parameters were assessed in tracheotomized newborn rats after pressure-controlled 
artificial ventilation with either room air or 100% oxygen during a short period of 5 
hours. 
Both in Nitrofen-exposed rats with CDH and in control rats, wet lung weight increased 
during gestation. At term, rats with CDH had significantly lower mean lung weights than 
control rats. Neither group differed in protein and DNA content per mg lung or SOD, 
catalase, and GPX activity per mg DNA before and at birth. After artificial ventilation of 
neonates with room air and 100% oxygen, SOD activity tended to decrease, whereas 
catalase activity remained virtually unchanged in the lungs from rats with CDH. However, 
GPX activity in these lungs was reduced to 80% of initial activity at term after ventilation 
with air and to 70% after ventilation with 100% oxygen. The present finding of a decline 
in GPX activity in this animal model after a short period of artificial ventilation may 
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indicate that the rat neonate with CDH is at risk to develop oxygen related lung damage 
(Sluiter et al. 1992). 
7.6 Research Perspectives 
The remaining research questions which should be answered using the different animal 
models to elucidate the etiology and pathogenesis of CDH are summarized in the table: 
Aspects of pulmonary development 
Morphogenesis 
- interaction lung bud - mesenchyme 
- branching pattern 
- vasculature - bloodflow 
- relationship with heart, liver, diaphragm 
- closing of the pleuroperitoneal canals 
Differentiation 
- epithelial changes 
* type I and type II cells 
- hormonal influences 
* thyroxine 
* glucocorticoids 
- antioxidant enzymes 
- release of vasoactive substances 
With respect to the lung, the understanding of morphogenesis relies on knowledge of cell 
movement, cell adhesion, cell growth, and cellular differentiation. Epithelial-mesenchymal 
interactions play key roles in these processes, while extracellular matrix molecules 
regulate mesenchymal-epithelial interaction during organ formation. A number of growth 
factors such as epidermal growth factor, fibroblast growth factor and others are known to 
be involved in cellular proliferation and differentiation (Warburton et al. 1993). 
Use of serumless chemically defined organ culture systems, transgenic mice, or other 
models can possibly contribute to further basic understanding of pulmonary development. 
Pediatric surgeons have the unique opportunity to share their knowledge of congenital 
anomalies such as congenital diaphragmatic hernia with knowledge and skills gained by 
scientists in laboratories of cell biology and genetics. 
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8.1 The Nitrofen model versus the human situation 
As mentioned in the introduction of this thesis, the mortality rate of congenital 
diaphragmatic hernia (CDH) has not improved in the last 30 years, despite the 
development of antenatal diagnostic procedures, advanced surgical techniques, and 
intensive perioperative care. The abnormalities of the lung, i.e. pulmonary hypoplasia and 
persistent pulmonary hypertension, are the main causes of the high morbidity and 
mortality rates. To obtain better insight into the pathogenesis of CDH and the resulting 
histologic abnormalities, we have directed our attention to the early and late fetal lung 
development and the closing process of the diaphragm in our rat model for CDH and 
pulmonary hypoplasia. This rat model is based on the use of 2,4-dichlorophenyl-p-
nitrophenylether (Nitrofen), a herbicide with teratogenic effects on the development of 
lung and diaphragm. In addition, we have tried to further elucidate the mode of action of 
Nitrofen. 
In the rat the lung primordium is visible from day 12 of gestation, initially as an 
outgrowth of the bottom of the foregut, and on day 13 as a triplicate tube growing in 
caudal direction. After Nitrofen-exposure on gestational day 10, the early growth of the 
lung, as measured in serial longitudinal sections on day 13, is reduced (Brandsma et al. 
1994a). Staining of normal lungs and Nitrofen-exposed lungs of approximately this 
gestational age with antibodies against the proliferation marker PCNA (proliferating cell 
nuclear antigen) and against some markers which are known to be of importance for the 
differentiation of tissues (collagen III and IV, fibronectin, and laminin) does not reveal 
any differences between the two groups. In other words, using these techniques, no 
difference in proliferation rate or differentiation signals is demonstrable between normal 
fetal rat lungs and (smaller!) Nitrofen-exposed fetal rat lungs (this thesis, chapter 5). 
Two days later (day IS), clear evidence of disturbed diaphragmatic development leaving 
parts of the liver uncovered is visible by scanning electron microscopy in Nitrofen-
exposed rat embryos (Kluth et al. 1993). On the next days the liver is seen inside the 
thoracic cavity, and from day 22 displaced bowel loops are present in the thoracic cavity 
as well. In those rat fetuses with massive liver protrusion, the lungs are hypoplastic, 
indicating that growth impairment of the lung results from a competition for space in the 
embryonic thoracic cavity (Kluth et a1. 1993). 
From at least day 19 onwards, Nitrofen-exposed fetal rat lungs have smaller lung volumes 
and lung tissue volumes as determined by morphometric techniques (Brandsma et al. 
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1994b). Between days 20 and 22 these lungs are atelectatic, and retarded with respect to 
the development of the future air spaces if CDH is present. The differentiation of 
immature cuboid type II cells into mature type II cells (Brandsma et al. 1993) and into 
squamous type I cells (Brandsma et a!. 1994b) is also retarded, resulting in relatively 
more type II cells lining the alveolar surfaces. This retardation of type II cell development 
does not have an obvious impact on the composition of extracellular surfactant (Brandsma 
et a!. 1993). 
In neonatal lungs from Nitrofen-exposed rats, a peripheral extension of the muscular 
arteries together with an increase in medial wall thickness is present both at the level of 
conducting airways as well as at the level of the terminal bronchioles (Tenbrinck et a!. 
1992). 
As in the Nitrofen model CDH in humans is accompanied by ipsilateral and (to a lesser 
extent) contralateral hypoplasia of the lungs. Histologic studies describing the different 
stages during abnormal lung development and the resulting morphology in patients with 
CDH have diverging results. A lower number of bronchial branches and alveoli, 
retardation of alveolar development, the presence of more cuboidal cells and atelectasis 
(Areechon and Reid 1963; Boyden 1972; Campanale and Rowland 1955; George et al. 
1987; Kitagawa et al. 1971; Nakamura et a!. 1991), and increased muscularity of the 
pulmonary vascular bed (Beals et a!. 1992; Bohn et al. 1987; Geggel et al. 1985; Levin 
1978) are demonstrated. 
As stated before, the mode of action by which Nitrofen exerts its teratogenic effects is 
largely unknown. Timing and dosage of the administration of the compound is crucial: 
Nitrofen administered to rats on day 10 of pregnancy results in leftsided hernias, while 
administration on day 12 results in rightsided hernias (Kluth et al. 1990); exposure on 
other days induces heart, kidney, or other malformations (Burke Hurt et a!. 1983; Costlow 
and Manson 1981; Gray et a!. 1983; Lau et a!. 1986; Ostby et a!. 1985). Apparently, the 
teratogenic time window differs per organ, and sometimes even within one organ. Results 
from several research groups (Gray and Kavlock 1983; Manson et a!. 1984; Manson 
1986) are suggesting an interference of Nitrofen with thyroid hormone function. The 
stereochemical configuration of Nitrofen resembles that of triiodothyronine (T,) and 
thyroxine (T4) to a great extent while application of Nitrofen to pregnant mother rats 
resulted in a decrease in thyrotropin-stimulating hormone and T4 , without major alterations 
of T3 in the mothers as well as a decrease of T4 in the fetuses (Gray and Kavlock 1983; 
Manson et al. 1984). Combined application of Nitrofen and T4 to rats that had been 
thyroidectomised resulted in 70% reduction of the frequency of congenital anomalies in 
the offspring (Manson et a!. 1984). Our own in vitro experiments show that Nitrofen 
inhibits the binding of triiodothyronine (T,) to the nuclear T,-receptor (Brandsma et a!. 
1994c). Consequently, Nitrofen-inducable defects, such as CDH and pulmonary 
hypoplasia, might result from a decreased binding of T, to its receptor. A possible 
explanation for a teratogenic time window is that the expression of the nuclear T]-receptor 
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differs in time per organ. These studies are currently under way in our laboratory using 
immunohistochemistry and in situ hybridization. 
It is lmown that thyroid hormone plays a significant role during the last phases of lung 
development, especially on the surfactant producing type II alveolar epithelial cells. This 
has long been assumed the only effect of thyroid hormone on pulmonary development. 
However, based on our own resuIts (Brandsma et al. 1994c), and on the fact that transfer 
of thyroid hormone through the placenta takes place in humans (Vulsma et al. 1989), a 
role of thyroid hormone during early fetal lung development can not be excluded. 
Knowledge of the mode of action of Nitrofen may eventually unravel the course of events 
in humans, and provide directions for the therapy or even the prevention of this serious 
anomaly. 
In a study on the etiological aspects of CDH in humans, Bos et al. (1994) do not show 
any association with a list of teratogens, nor with maternal thyroid dysfunction. They 
approached all parents of children with CDH admitted to their pediatric surgical intensive 
care unit from 1984 to 1990. Questions were asked related to potential teratologic data. In 
addition, blood was drawn immediately postpartum from nine mothers, and maternal 
antibodies were determined against thyroglobulin, thyroid microsomes, and thyroid 
stimulating hormone receptors. No specific association was found to be significant. A 
large population-based, case-control study of Khoury et al. (1989) showed no relationship 
between the risk of birth defects and history of maternal hypothyroidism either. 
In conclusion, as long as the etiology of CDR and pulmonary hypoplasia is unknown, we 
have to be very careful with the extrapolation of lmowledge obtained in the rat model to 
the human situation, even when the model seems as perfect as the Nitrafen model does. 
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This study was undertaken to investigate the pathogenetic aspects of pulmonary 
hypoplasia in congenital diaphragmatic hernia (CDR). CDR is a birth defect in which the 
organs of the abdominal cavity herniate into the chest cavity through an incompletely 
closed diaphragm. It is accompanied by unilateral or bilateral pulmonary hypoplasia with 
resultant respiratory failure after birth in the majority of the cases. The incidence of CDR 
is 1:3000 liveborns, the etiology is unknown, and the mortality rate is 30-50%. 
For this study we used a rat model of CDR and pulmonary hypoplasia induced by the 
herbicide 2,4-dichlorophenyl-p-nitrophenyl (Nitrofen). 
Chapter 1 introduces the problem of CDR and pulmonary hypoplasia. An outline of 
literature data on normal and abnormal development of fetal human and rat lungs is given. 
In chapter 2 the alveolar epithelial composition and architecture of the late fetal 
pulmonary acinus in hypoplastic and normal rat lungs is described. In this study we used 
lung tissue from normal control and Nitrofen-exposed fetal Sprague Dawley rats aged 18-
22 days. Sections were stained with hematoxylin and eosin or incubated with anti-
Surfactant Protein A (SP-A) antiserum to identify developing alveolar epithelial cells, and 
studied by light microscopy. Morphometric techniques were used to quantitate the 
differences between the control and the Nitrofen-exposed groups. We found that Nitrofen-
exposed fetal rat lungs (I) have smaller lung volumes and lung tissue volumes from at 
least day 19 onwards; (2) are retarded with respect to the differentiation of cuboid type II 
cells into squamous type I cells; (3) have smaller total volumes of type II cells if CDR is 
present, but their alveolar surfaces are lined by relatively more type II cells and less type I 
cells whether or not CDR is present; (4) are atelectatic, and retarded with respect to the 
development of the future air spaces between days 20 and 22 if CDR is present. 
To study the ultrastructural features and functional maturity of the alveolar epithelial cells 
in hypoplastic and normal fetal rat lungs, we used the transmission electron microscope, 
and determined phospholipid fractions and SP-A content in bronchoalveolar lavage fluid. 
The results are described in chapter 3. We found that there are less mature multilamellar 
bodies (MLBs) on day 20 and more glycogen on day 22 in type II cells of Nitrofen-
exposed lungs, suggesting a retarded maturation of these type II cells in hypoplastic lungs 
compared to those in control lungs. The phospholipid composition as well as the amount 
of SP-A per mol phospholipid in bronchoalveolar lavage fluid from fetal rat lungs is the 
same in both the Nitrofen-exposed and the control group. Thus, the composition of 
extracellular surfactant is probably the same in both groups. 
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In chapter 4 the natural history of CDH associated with pulmonary hypoplasia is studied 
by scanning electron microscopy. We found that impaired lung development is 
proportional to the size of the liver mass inside the thoracic cavity. This indicates that 
growth impairment is not the result of lung compression in the fetus but rather the result 
of growth competition in the embryo: the liver that grows faster than the lung reduces the 
available space. If the remaining space is too small, pulmonary hypoplasia will result. 
In the next study, described in chapter 5, we have tried to distinguish between effects of 
Nitrofen on early lung proliferation and on early lung differentiation. As criteria for 
proliferation were taken: measurements of length of the pulmonary primordium and 
staining for proliferating cell nuclear antigen (PCNA). As differentiation markers we used 
antibodies against the collagens III and IV, laminin, and libronectin. It was shown that the 
early growth of the lung primordium was reduced on day 13 after exposure to Nitrofen on 
day 10. No differences between normal and Nitrofen-exposed fetal rat lungs were found 
using the other markers. 
Data from the literature suggest that Nitrofen might exert its teratogenic action via an 
alteration of thyroid hormone metabolism. Therefore, we investigated the effect of 
Nitrofen on the binding of thyroid hormone to the Oil and ill form of the thyroid hormone 
receptor obtained from bacteria by recombinant DNA techniques. We found that Nitrofen 
decreases the binding of T3 to the thyroid hormone receptor in a non-competitive way. 
Consequently, rat lung hypoplasia might result from the decreased binding of T3 to its 
receptor after exposure to Nitrofen. This study is described in chapter 6. 
Chapter 7 offers a review and discussion of the most important results so far obtained in 
our Nitrofen rat model, and formulates some clinical perspectives and research questions. 
Finally, in cbapter 8, a comparison is made between the human situation and the Nitrofen 
model for CDH and pulmonary hypoplasia. It is concluded that we have to be careful with 
the extrapolation of knowledge obtained in the rat model to the human situation, even 
when the model seems as perfect as the Nitrofen model does. 
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In dit proefschrift wordt verslag gedaan van een onderzoek naar de pathogenetische 
aspecten van longhypoplasie bij congenitale hernia diaphragmatica (CDH). CDH is een 
aangeboren afwijking waarbij de buikorganen via een defect in het middenrif in de 
borsthoIte hernieren. In vrijwel alle gevallen gaat dit gepaard met uni- of bilaterale 
longhypoplasie en ernstige ademhalingsproblemen na de geboorte. CDH komt voor bij 1 
op de 3000 pasgeborenen, de etiologie is onbekend en de mortaliteit is 30 tot 50%. 
Voor deze studie hebben we gebruik gemaakt van een diermodel: toediening van het 
landbouwgif 2,4-dichlorophenyl-p-nitrophenyl (Nitrofen) aan zwangere ratten resuIteert in 
CDH en longhypoplasie bij de nakomelingen. 
In hoofdstuk 1 wordt het probleem van CDH en longhypoplasie geYntroduceerd. Het bevat 
een overzicht van gegevens uit de literatuur over normale en abnormale ontwikkeling van 
de foetale long bij de mens en bij de rat. 
In hoofdstuk 2 wordt de samenstelling van het alveolaire epitheel en de architectuur van 
de laat-foetale longacinus in hypoplastische en normale rattelongen beschreven. Voor deze 
studie hebben we longweefsel van normale en van aan Nitrofen blootgestelde foetale 
Sprague Dawley ratten gebruikt, varierend in leeftijd van 18 tot 22 dagen. Van dit 
longweefsel werden coupes gesneden en gekleurd met hematoxyline en eosine of 
geYncubeerd met anti Surfactant Protein A (SP-A) antiserum om alveolaire epitheliale 
cellen te herkennen. Morfometrische technieken werden gebruikt om de verschillen tussen 
de controlegroep en de Nitrofen-groep te kwantificeren. We hebben gevonden dat aan 
Nitrofen blootgestelde foetale rattelongen (I) k1einere longvolumina en longweefsel-
volumina hebben tenminste vanaf dag 19; (2) een vertraagde differentiatie van kubische 
type II cellen in platte type I cellen hebben; (3) een k1einer totaal volume van type II 
cellen hebben als er een hernia aanwezig is, maar dat het alveolaire oppervlak bekleed is 
met relatief meer type II cellen en minder type I cell en ongeacht de aanwezigheid van een 
hernia; (4) atelectatisch zijn, en vertraagd wat betreft de ontwikkeling van de toekomstige 
luchtruimten tussen dag 20 en 22 als er eeo hernia aanwezig is. 
Om de uItrastructuur en de functionele rijpheid van de alveolaire epitheliale cellen in 
hypoplastische en normale foetale rattelongen te bestuderen hebben we gebruik gemaakt 
van de transmissie electronenmicroscoop. Tevens hebben we de fosfolipide fracties en het 
SP-A gehaIte in bronchoalveolaire lavage vloeistof gemeten. De resultaten zijn beschreven 
in hoofdstuk 3. We hebben gevonden dat er in de type II cellen van aan Nitrofen 
blootgestelde longen minder rijpe muItilamellaire lichaampjes (MLBs) zijn op dag 20 en 
meer glycogeen op dag 22. Dit suggereert een vertraagde rijping van deze type II cellen in 
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hypoplastische longen in vergelijking met normale longen. De fosfolipid compositie en de 
hoeveelheid SP-A per mol fosfolipid in de bronchoalveolaire lavage vloeistof is hetzelfde 
in de controle groep en de Nitrafen groep. Kortom, de samenstelling van het 
extracellulaire surfactant verschilt niet tussen beide groepen. 
In hoofdstuk 4 is het ontstaan van CDR met longhypoplasie bestudeerd met behulp van de 
scanning electronenmicroscoop. We hebben gevonden dat de verstoring van de 
longontwikkeling evenredig is met de hoeveelheid lever in de borsthoIte. Dit betekent dat 
groeivertraging niet zozeer het resultaat is van longcompressie in de foetus maar eerder 
van competitie VOOI ruimte in het embryo: de snelgroeiende lever reduceert de 
beschikbare ruimte voor de long. Ais de resterende ruimte te klein is zaI longhypoplasie 
ontstaan. 
In de volgende studie, beschreven in hoofdstuk 5, hebben we geprobeerd een onderscheid 
te maken tussen effecten van Nitrofen op de vroege longproliferatie en de vroege 
longdifferentiatie. Ais criteria VOOI proliferatie hebben we genomen: lengte van het 
longprimordium en kleuring met proliferating cell nuclear antigen (PCNA). Als 
differentiatie markers hebben we antisera tegen collageen III en IV, fibronectine en 
laminine gebruikt. Op dag 13 bleek de vroege groei van het longprimordium vertraagd te 
zijn na blootstelling aan Nitrafen op dag 10. Er werden, na gebruik van de overige 
markers, geen andere verschillen gevonden tussen de longen uit de controle en de Nitrofen 
groep. 
Gegevens uit de literatuur suggereren dat Nitrofen zijn teratogene werking zou kunnen 
uitoefenen via een verandering van de schildldierhormoon huishouding. Dat bracht ons er 
toe het effect van Nitrofen op de binding van schildklierhormoon aan de O!, en de 13, vorm 
van de schildklierhormoon receptor te bestuderen. We vonden dat Nitrofen de binding van 
T) aan de schildklierhormoon receptor vermindert op een niet-competitieve manier. Dus, 
longhypoplasie bij de rat zou kunnen ontstaan door de verminderde binding van T, aan 
zijn receptor na blootstelling aan Nitrofen. Deze resultaten zijn beschreven in hoofdstuk 
6. 
Hoofdstuk 7 biedt een overzicht en bespreking van de belangrijkste resultaten die we tot 
nu toe hebben verkregen met behulp van het Nitrofen diermodel. Tevens worden 
vooruitzichten voor de kliniek en daarmee nog samenhangende onderzoeksvragen 
geformuleerd. 
Uiteindelijk wordt in hoofdstuk 8 de situatie bij de mens vergeleken met die bij de rat in 
het Nitrofen model voor congenitale hernia diaphragmatica en longhypoplasie. De 
conc1usie is dat we nog voorzichtig moeten zijn met de extrapolatie van kennis verkregen 
uit het rattemodel naar de menselijke situatie, zelfs aIs het model zo perfect lijkt als dit 
Nitrofen model. 
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